WO2011129428A1 - Cosmetic composition containing plum extract - Google Patents

Cosmetic composition containing plum extract Download PDF

Info

Publication number
WO2011129428A1
WO2011129428A1 PCT/JP2011/059358 JP2011059358W WO2011129428A1 WO 2011129428 A1 WO2011129428 A1 WO 2011129428A1 JP 2011059358 W JP2011059358 W JP 2011059358W WO 2011129428 A1 WO2011129428 A1 WO 2011129428A1
Authority
WO
WIPO (PCT)
Prior art keywords
ume
extract
present
skin
composition
Prior art date
Application number
PCT/JP2011/059358
Other languages
French (fr)
Japanese (ja)
Inventor
浩一 瀬田
暢浩 加藤
大二郎 大谷
貴也 峯尾
郁子 安達
文 佐々木
Original Assignee
ワミレスコスメティックス株式会社
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ワミレスコスメティックス株式会社 filed Critical ワミレスコスメティックス株式会社
Publication of WO2011129428A1 publication Critical patent/WO2011129428A1/en

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/73Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
    • A61K36/736Prunus, e.g. plum, cherry, peach, apricot or almond
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105Plant extracts, their artificial duplicates or their derivatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/55Phosphorus compounds
    • A61K8/553Phospholipids, e.g. lecithin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/63Steroids; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A61K8/86Polyethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/92Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
    • A61K8/922Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783Angiosperms [Magnoliophyta]
    • A61K8/9789Magnoliopsida [dicotyledons]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/02Preparations for care of the skin for chemically bleaching or whitening the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/08Anti-ageing preparations
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/24Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs

Definitions

  • the present invention relates to a composition containing extracts from various parts of ume.
  • the composition of the present invention is particularly useful as a cosmetic or a food or drink.
  • Patent Document 1 provides a cosmetic characterized by blending a ume seed extract.
  • radical scavenging action collagenase activity inhibitory action (collageno kit CLN-100) was obtained from an extract obtained from ground pulverized seeds of ume (variety unknown) using water, ethanol, 1,3-butylene glycol, or methanol as a solvent.
  • Use It seems to be using fluorescently labeled type I collagen.
  • Hyaluronidase activity inhibitory action (details are unknown, such as origin of hyaluronidase used in the measurement), changes in cell hue in B16 cells confirmed Has been.
  • lotions, shampoos, creams, body gels, hair packs, and granular bath preparations containing ume seed extract have been prepared, and sensory tests have confirmed the feeling of use.
  • Patent Documents 2 to 4 include at least one selected from the group consisting of plum tree trunks, plum tree branches, plum tree leaves, plum tree stems, plum tree roots, plum meat, ume seed shells and ume seeds.
  • methanol extract of Minamitakaume Jin and / or leaf stem part has an effect on gastric mucosal damage by methanol in rats, a radical (DPPH) elimination effect, an inhibitory effect on blood sugar level increase after glucose load in healthy rats, Inhibition of aldose reductase, promotion of aggregation when platelets of healthy rabbits were washed with platelet-activating factor (PAF), suppression of D-galactosamine / LPS-induced liver inflammation in healthy mice, D-in rat primary cultured hepatocytes Inhibition of galactosamine-induced acute hepatitis and inhibition of NO acid from macrophages in the abdominal cavity of healthy mice by stimulation with LPS, tyrosinase inhibitory action, radical (DPPH) elimination action, and washing of healthy rabbits of ume flower methanol extract Aggregation-promoting action has been confirmed when platelets are stimulated with platelet-activating factor (PAF)
  • PAF platelet-activating factor
  • Patent Document 5 describes a collagen production promoter characterized by containing an extract from the fruit part of ume as an active ingredient.
  • human fibroblasts are extracted from a dried fruit juice obtained by washing, crushing, and enucleating the ume (variety unknown) fruit juice and using a mixed solvent of ethanol and water. Has been confirmed to promote collagen production (using anti-human collagen type I rabbit IgG).
  • JP 2002-284633 A JP 2000-239297 A JP 2002-370922 A JP 2004-115542 A JP 2006-176425 A
  • the present inventors have focused on a material called ume having a high pharmacological effect, and have developed a cosmetic characterized by comprising a fermented ume juice (No. 2526362).
  • a fermented ume juice No. 2526362
  • the present inventors have completed the present invention by discovering previously unknown actions such as elastase activity inhibitory action, gelatinase activity inhibitory action, Maillard reaction inhibitory action and the like.
  • the present invention provides the following: [1] A group consisting of water, water vapor, purified water, mineral water, ethanol, propylene glycol, and 1,3-butylene glycol from one or more sites selected from roots, branches and bark of ume A cosmetic composition containing, as a dry powder, 0.05 to 250 mg / 100 g of an extract from one or more solvents selected from the group consisting of 0.015 to 5 g / 100 g of an emulsifier. [2] The composition according to [1], wherein the emulsifier is lysolecithin, PEG-60 hydrogenated castor oil, hydrogenated lecithin, soybean sterol, or any combination thereof.
  • FIG. 1 is a photograph showing the results of a gelatinase activity inhibitory effect test.
  • FIG. 2 is a photograph showing the results of the Maillard reaction inhibitory effect test.
  • FIG. 3 is a photograph showing the results of a test for examining the amount of emulsifier.
  • FIG. 4 is a photograph showing the results of a test for examining the amount of emulsifier.
  • ume refers to ume (plum, scientific name: Prunus mume), which is a deciduous tree of the genus Rosaceae. Ume can be roughly divided into flower plums and real plums.
  • Examples of real plums are Bungo, Shirakaga, Bakujuku, Moon World, Koshu Minato, Tammei, Kojo, and Minami High School.
  • the term “Bungo” for ume varieties refers to Bungo classified as real plum, unless otherwise specified.
  • ume refers to a plant body of a ume plant or a part thereof unless otherwise specified.
  • Parts include fruits, seeds, organs or parts thereof (including leaves, roots, stems, flowers, stamens, pistils, fragments thereof), plant culture cells, callus, protoplasts, transformed plant cells, traits Converted plants are included.
  • “Wakae” refers to a branch in which a new tree that grows in early spring begins to grow and grows about 5 to 30 cm, and the skin is soft, unless otherwise specified.
  • the term “root” includes fine roots, medium roots and thick roots, as well as old roots and others. Fine roots are those with a diameter of less than 3 mm.
  • the middle root means one having a diameter of 3 mm or more and less than 10 mm.
  • a radish is one having a diameter of 10 mm or more.
  • Old root is a general term for roots obtained from ume plants over 30 years old.
  • any part of ume can be used effectively, but from the viewpoint that various effects can be expected, roots and branches (especially young branches) are preferable, and roots are more preferable.
  • elastase refers to a protease having elastin as a typical substrate, unless otherwise specified.
  • Elastin is a kind of a hard protein that is rich in elasticity and constitutes connective tissues, tendons, aortic skin, cervical cord and the like of higher animals. There are many crosslinks between peptide chains constituting this protein, which brings about elasticity.
  • the term “gelatinase” is a protease using a type IV collagen that is a basement membrane component as a typical substrate, unless otherwise specified, and is a matrix metalloproteinase (MMP) group of MMP-2 and MMP-9. Is included.
  • MMP matrix metalloproteinase
  • the presence or absence and / or degree of the ability to inhibit the target gelatinase activity can be confirmed and measured appropriately by those skilled in the art using known means. For example, it can be carried out using a commercially available MMP marker for gelatin zymography, which contains MMP-2, ProMMP-2, ProMMP-9 or a mixture thereof.
  • MMP-2 MMP-2, ProMMP-2, ProMMP-9 or a mixture thereof.
  • MMP-9 for gelatin zymography
  • Collagenase refers to a type of protease using type I collagen as a typical substrate, unless otherwise specified.
  • Collagenase includes MMP-1, which is a matrix metalloproteinase (MMP) that degrades type I and type III collagen, which are the main components of the skin matrix.
  • MMP-1 matrix metalloproteinase
  • Collagen is a main component of the extracellular matrix of animals, and is known to have a physical function of maintaining the structure and exhibit cell adhesion activity. It is also contained in large amounts in the skin and is related to elasticity and strength. There are I to VIII in collagen.
  • the presence or absence and / or degree of the ability to inhibit the target collagenase activity can be confirmed and measured appropriately by those skilled in the art using known means. For detailed conditions, reference can be made to the Examples section of this specification. In the present invention, the presence or absence and / or degree of inhibition of collagenase activity is based on the method described in the examples of the present specification, unless otherwise specified.
  • hyaluronidase refers to an enzyme that lowers the molecular weight of hyaluronic acid, unless otherwise specified, and an enzyme that hydrolyzes the N-acetyl-D-hexosaminide bond of hyaluronic acid.
  • Hyaluronidase is present in the skin.
  • Hyaluronic acid is a kind of glycosaminoglycan having a repeating structure of only disaccharides of O- ⁇ -D-glucuronosyl (1 ⁇ 3) -N-acetyl- ⁇ -D-glucosaminyl (1 ⁇ 4) units. It is present in connective tissues such as animal joint fluid and dermis.
  • fibroblast activation means that the proliferation ability of normal human dermal fibroblasts (NHDF) can be enhanced.
  • the presence / absence / degree of cell proliferation can be determined by counting the number of living cells. Various methods are known for determining the number of viable cells.
  • the presence and / or degree of the ability to activate the target fibroblasts can be confirmed and measured appropriately by those skilled in the art using known means. For detailed conditions, reference can be made to the Examples section of this specification. In the present invention, the presence or absence and / or degree of fibroblast activation activity is based on the method described in the examples of the present specification, unless otherwise specified.
  • melanin production inhibition refers to inhibition of melanocyte activator synthesis, inhibition of melanocyte activator, tyrosinase synthesis / maturation inhibition, melanin synthase (tyrosinase etc.) activity inhibition, melanin, unless otherwise specified
  • melanin is an oxidation polymer derived from tyrosine.
  • melanogenesis occurs in melanophores and melanocytes differentiated from neural crest-derived melanoblasts.
  • the aromatic amino acid tyrosine changes stepwise within the melanosome, and finally polymerizes non-enzymatically into melanin, followed by the formation of melanin granules.
  • the component of the agent of the present invention not only has high melanin production inhibitory activity but is not cytotoxic.
  • Such a preferable effect can be represented by a value obtained by multiplying the melanin production inhibition rate and the cell survival rate, as described in Examples described later.
  • a person skilled in the art confirms and measures the presence and / or degree of the ability to suppress melanin production and the presence and / or degree of cytotoxicity using known means as appropriate, for example, using B16 melanoma cells. can do.
  • known means for example, using B16 melanoma cells. can do.
  • the presence and / or degree of melanin production inhibitory activity is based on the method described in the examples of the present specification, unless otherwise specified.
  • “Maillard reaction” refers to a reaction in which a brown substance (melanoidin) is generated from a sugar and a protein by an aminocarbonyl reaction, unless otherwise specified.
  • the Maillard reaction is usually a non-enzymatic reaction in which an Amadori rearrangement product (Amadori compound) is generated after a reducing sugar reacts with an amino group of a protein to form a Schiff base. Then, through complex reactions such as oxidation, dehydration, condensation, intramolecular and intermolecular cross-linking, the mixture gradually becomes yellowish brown and AGEs (advanced glycation end products) which are late stage products of the Maillard reaction are produced.
  • Amadori rearrangement product Amadori compound
  • the Maillard reaction that occurs in vivo is considered to be involved in the formation of brown spots on the skin seen in diabetic patients.
  • AGE is included in the pigment that causes brown spots.
  • In vivo Maillard reaction has also been shown to be associated with lifestyle-related diseases, diseases accelerated by aging (eg, diabetic complications, Alzheimer's disease, arteriosclerosis).
  • AGE is a generic name for various structures produced from the Amadori rearrangement product through complex reactions such as oxidation, dehydration, and condensation, including carboxymethyllysine, pyralin, pentosidine, croslin, imidazolone, etc.
  • a polymer of protein dimer or higher is also known as AGE.
  • the term “antioxidation” means that the active oxygen is suppressed (not generated, erased, or suppressed) unless otherwise specified.
  • a person skilled in the art can appropriately confirm and measure the presence and / or degree of the antioxidant ability of a subject using known means.
  • DPPH (1,1-diphenyl-2-picrylhydrazyl) radical scavenging, superoxide dismutase (SOD) -like action, hydrogen peroxide (H 2 O 2 ) scavenging, TRAP (Total Radical-trapping Antioxidant Parameter), FRAP (Ferric Reducing Ability of Plasma), ⁇ -carotene fading, etc.
  • SOD superoxide dismutase
  • H 2 O 2 hydrogen peroxide
  • TRAP Total Radical-trapping Antioxidant Parameter
  • FRAP Frerric Reducing Ability of Plasma
  • ⁇ -carotene fading etc.
  • the presence or absence and / or degree of antioxidant ability refers to the methods described in the examples of the present specification (DPPH radical elimination method, SOD method, H 2 O 2 elimination method) unless otherwise specified. It depends on either.
  • “suppressing the progress of aging” means delaying the progress of aging. Suppression of the progress of aging is sometimes expressed as anti-aging or anti-aging.
  • the extract of ume that can be used in the composition of the present invention refers to a product obtained by extracting each part of the ume with a solvent (including liquid and gaseous states). You may use each part of a ume after freeze-drying.
  • the solvent to be extracted include water (including a liquid obtained by subjecting a specific portion of ume to steam distillation), steam, purified water, mineral water, lower alcohols (methanol, ethanol, 1-propanol, 2-propanol, 1-butanol, 2-butanol, etc.), polyhydric alcohols (glycerin, propylene glycol, 1,3-butylene glycol, etc.), ketones (acetone, methyl ketone, etc.), ethers (diethyl ether, tetrahydrofuran, etc.) ).
  • polar solvents such as steam, purified water, steam distilled liquid, mineral spring water, lower alcohols, polyhydric alcohols, particularly preferably purified water, steam distilled liquid, mineral water, ethanol, propylene glycol, 1,3 -Butylene glycol is good. These solvents may be used alone or in combination of two or more.
  • the composition of the present invention may also contain an extract obtained from each of a plurality of extraction solvents.
  • the composition of the present invention contains an ethanol extract (an extract using 90% or more of ethanol), according to the study by the present inventors, the ume ethanol extract contains a hardly water-soluble component. Therefore, in order to solubilize in the composition and enhance the stability, it is preferable to further include an emulsifier as described later.
  • an ethanol extract an extract using ethanol having a purity of 90% or more
  • water including a liquid obtained by subjecting a specific part of ume to steam distillation
  • the purity of the solvent and the concentration of the mixed solvent for example, 95% ethanol
  • it is based on the volume unless otherwise specified.
  • a steam distilled liquid is used as an extraction solvent and is added to the composition as it is.
  • the steam distilled liquid is obtained by continuously applying heated steam to a target (for example, ume fruit or ume shoots) in a container and cooling and collecting the steam flowing out from the container.
  • the obtained liquid may contain various components derived from the subject.
  • composition of the present invention is composed of two or more components, preferably in a form suitable for external use on the skin or as a food, and more preferably in the form of a cosmetic or health food.
  • the composition or agent of the present invention does not include existing cosmetics and the like. Regarding the present invention, the description of the composition also applies to the agent unless otherwise specified.
  • the content of the ume extract is not particularly limited as long as the intended effect is exhibited.
  • concentration of the ume extract in an agent by this invention it is the value calculated based on the weight of the ume extract with respect to the composition total weight except the case where it describes especially.
  • the weight of the ume extract was soaked in a solvent so that the dried ume portion was 5% W / W, and was kept at 20 to 40 ° C. for 3 to 5 days (medium 2 to 4). It is the weight expressed as the filtrate or dried product of the extract obtained by extraction between the two days. That is, the extract or dry matter obtained under other conditions is converted into the equivalent amount under the above conditions.
  • composition of the present invention includes fats, waxes, hydrocarbons, fatty acids, alcohols, esters, amino acids, vitamins, which are components used in ordinary external preparations, as long as the desired effects are not impaired.
  • Surfactants, pH adjusters, antiseptics, fragrances, moisturizers, powders, UV absorbers, thickeners, pigments, antioxidants, whitening agents, anti-inflammatory agents, anti-wrinkle agents, rough skin improvers, Components such as acne agents, alkalis, chelating agents, sequestering agents and the like can also be blended.
  • ingredients such as sodium sulfate, sodium hydrogen carbonate, calcium carbonate, potassium chloride, oily ingredients, emulsifiers, succinic acid, herbal medicines, inorganic pigments, fragrances, and pigments, which are components used in ordinary bath additives, You can also.
  • composition of the present invention can also be prepared into various dosage forms such as a solid agent, a semi-solid agent, and a liquid agent depending on the purpose of use.
  • the composition of the present invention can be in any form of cosmetics, quasi drugs, and pharmaceuticals.
  • cosmetics as skin care cosmetics, facial soap, facial cream, facial cleansing foam, lotion (replenishes the skin with moisture and moisturizing ingredients and keeps the skin fresh and is usually a transparent or translucent liquid. Depending on the intended use.
  • an amount corresponding to the steam extract obtained by the method described in Example 1 of the present invention preferably, a steam distilled liquid of ume shoots.
  • 10 to 50 g / 100 g, preferably 15 to 45 g / 100 g, more preferably 20 to 40 g / 100 g, and a steam distilled liquid obtained by the method described in Example 1 of the present invention preferably , A steam distilled liquid of ume fruit
  • a steam distilled liquid of ume fruit can be blended in an amount of 35 to 65 g / 100 g, preferably 40 to 60 g / 100 g, more preferably 45 to 55 g / 100 g.
  • 0.05 to 250 mg / 100 g, preferably 0.1 to 15 mg / 100 g, More preferably, 1-10 mg / 100 g can be blended, and the method described in Example 1 of the present invention
  • 0.05 to 15 g / 100 g, preferably 0.1 to 10 g / 100 g, more preferably 0.5 to 5 g / 100 g may be blended. It can. Also in this case, each may be blended alone in the above amounts, or may be blended in combination in the above amounts. It is more preferable to combine them.
  • blending amount of the ume extract in the present invention means an amount corresponding to the extract obtained by the method described in Example 1 of the present specification, unless otherwise specified.
  • the ume extract is extracted with the ume extract obtained by the method described in Example 1 of the present invention (preferably, extraction of ume root with a ume shoot branch steam distillate).
  • the amount corresponding to dry powder of ume extract (preferably, dry powder of extract of ume root with 95% ethanol) is 0.1 to 250 mg / 100 g, preferably 0.3 to 15 mg / 100 g, more preferably 0.5 to 10 mg. / 100g can be blended.
  • the ume extract and the dried product may be blended alone in the above amounts or in combination. It is more preferable to combine them.
  • the ume extract corresponds to the ume extract obtained by the method described in Example 1 of the present invention (preferably, the extract of the ume root by the ume shoot water vapor distillation solution). 0.01 to 30 g / 100 g, preferably 0.05 to 20 g / 100 g, more preferably 0.1 to 10 g / 100 g, and the amount of ume extract obtained by the method described in Example 1 of the present invention.
  • the amount corresponding to the ume steam distillate (preferably ume fruit steam distillate) obtained by the method described in Example 1 of the present invention is 5 to 70 g / 100 g, preferably 10 to 60 g / 100 g, more preferably 20 to 50 g / 100 g can be blended.
  • each extract may be blended alone in the above amount, or may be blended in combination in the above amount. It is more preferable to combine them.
  • the ume extract is used as an amount corresponding to the ume steam distillate (preferably the ume fruit steam distillate) obtained by the method described in Example 1 of the present invention. 20 to 80 g / 100 g, preferably 30 to 70 g / 100 g, more preferably 40 to 60 g / 100 g.
  • the ume extract corresponds to the ume extract obtained by the method described in Example 1 of the present invention (preferably, the extract of the ume root by the ume shoots steamed distillate). 0.1 to 20 g / 100 g, preferably 0.5 to 10 g / 100 g, more preferably 1 to 5 g / 100 g, and the dried ume extract obtained by the method described in Example 1 of the present invention.
  • an amount corresponding to powder preferably dry powder of extract of ume root with 95% ethanol
  • 0.01 to 250 mg / 100 g preferably 0.05 to 10 mg / 100 g, more preferably 0.2 to 5 mg / 100 g Can do.
  • each extract may be blended alone in the above amount, or may be blended in combination in the above amount. It is more preferable to combine them.
  • the composition of the present invention corresponds to a ume extract obtained by the method described in Example 1 of the present invention (preferably, an extract of ume roots using a ume sap branch steam distillation solution).
  • the amount can be 0.05 to 10 g / 100 g, preferably 0.1 to 5 g / 100 g, more preferably 0.5 to 2 g / 100 g, and the dried ume extract obtained by the method described in Example 1 of the present invention.
  • As an amount corresponding to powder preferably, dried powder of ume root extract with 95% ethanol
  • 0.01 to 250 mg / 100 g, preferably 0.05 to 5 mg / 100 g, more preferably 0.3 to 1 mg / 100 g Can do.
  • each extract may be blended alone in the above amount, or may be blended in combination in the above amount. It is more preferable to combine them.
  • composition of the present invention is in the form of a lip base
  • dried powder of ume extract obtained by the method described in Example 1 of the present invention preferably dried powder of ume root extract with 95% ethanol
  • an extract preferably, an extract of ume roots with a ume shoot steamed distillate and / or a purified water extract of ume roots
  • each extract may be blended alone in the above amount, or may be blended in combination in the above amount. It is more preferable to combine them.
  • the ume extract is converted into a ume extract obtained by the method described in Example 1 of the present invention (preferably, an extract of ume roots using a ume sap branch steam distillation solution).
  • a corresponding amount 0.01 to 30 g / 100 g, preferably 0.5 to 20 g / 100 g, more preferably 1 to 10 g / 100 g can be blended, and the ume extract obtained by the method described in Example 1 of the present invention.
  • 0.01 to the dry powder preferably, dried powder of ume root extract with 95% ethanol
  • 0.01 to 250 mg / 100 g preferably 0.05 to 10 mg / 100 g, more preferably 0.1 to 5 mg / 100 g can do.
  • each extract may be blended alone in the above amount, or may be blended in combination in the above amount. It is more preferable to combine them.
  • composition of the present invention is in the form of a cosmetic
  • an effective amount of an emulsifier is included to solubilize the ume extract.
  • emulsifiers are various effects of ume extract, namely elastase activity inhibition effect, gelatinase activity inhibition effect, collagenase activity inhibition effect, hyaluronidase activity inhibition effect, fibroblast activation (activity, effect), melanin production inhibition effect, Maillard
  • the reaction suppressing effect and the antioxidant effect can be synergistically enhanced.
  • emulsifiers that can be used in the present invention are lecithin, lecithin derivatives, lysophospholipid, polymer emulsifier, propylene glycol fatty acid ester, glycerin fatty acid ester, polyglycerin fatty acid ester, polyoxyethylene glycerin fatty acid ester, sorbitan fatty acid ester, poly Oxyethylene sorbitan fatty acid ester, polyoxyethylene sorbit fatty acid ester, polyoxyethylene lanolin, lanolin alcohol, beeswax derivative, polyoxyethylene hydrogenated castor oil, polyoxyethylene sterol, hydrogenated sterol, polyoxyethylene alkyl ether, polyoxyethylene poly Oxypropylene alkyl ether, polyoxyethylene alkyl ether phosphate / phosphate, polyethylene glycol fatty acid ester It is an ether.
  • lecithin and lecithin derivatives include fractionated lecithin, enzymatically degraded lecithin (including lysolecithin), and hydrogenated lecithin (sometimes referred to as “hydrogenated lecithin”). More specific preferable examples of the emulsifier that can be used in the present invention are expressed as lysolecithin, hydrogenated lecithin, hydrogenated lysolecithin (lysophospholipid, hydrogenated phospholipid, hydrogenated lysophospholipid) derived from soybean or egg yolk. There is also.). Lecithin and lecithin derivatives can also be used in combination.
  • emulsifiers include lysolecithin, PEG-60 hydrogenated castor oil, hydrogenated lecithin, soybean sterol, or any combination thereof in an amount effective to solubilize the ume extract in the composition of the present invention.
  • the blending amount is 0.015 g / 100 g or more, preferably 0.025 g / 100 g, more preferably 0.05 g / 100 g. In any case, it is preferably 5 g / 100 g or less, more preferably 2.5 g / 100 g or less.
  • the upper limit value may be determined in consideration of viscosity.
  • the composition of the present invention may contain 0.001 to 10 g / 100 g, preferably 0.002 to 5 g / 100 g, more preferably 0.002 to 3 g / 100 g.
  • composition of the present invention is in the form of a cosmetic, in a particularly preferred embodiment, it is used immediately after washing the face.
  • various effects of ume extract namely elastase activity inhibitory effect, gelatinase activity inhibitory effect, collagenase activity inhibitory effect, hyaluronidase activity inhibitory effect, fibroblast activation (activity, effect), melanin production inhibitory effect, Maillard reaction inhibitory effect and antioxidant effect can be synergistically enhanced.
  • composition of the present invention is in the form of a cosmetic
  • its production method is not particularly limited as long as the effect of the ume extract is not significantly reduced, and can be appropriately produced by those skilled in the art.
  • the production process includes a high-pressure emulsification treatment process.
  • the emulsified particles can be made fine and an emulsified state with high stability can be created.
  • a ume extract that is relatively difficult to disperse can be sufficiently dispersed and stabilized, facilitating blending.
  • the emulsified particles become finer, have better skin fit, increase permeability, and various effects of ume extract: elastase activity inhibitory effect, gelatinase activity inhibitory effect, collagenase activity inhibitory effect, hyaluronidase activity inhibitory effect, fiber
  • elastase activity inhibitory effect gelatinase activity inhibitory effect
  • collagenase activity inhibitory effect hyaluronidase activity inhibitory effect
  • fiber A cosmetic product that synergistically enhances blast cell activation (activity, effect), melanin production inhibitory effect, Maillard reaction inhibitory effect, and antioxidant effect can be produced.
  • the production process includes a deodorization process separately from or in combination with the high-pressure emulsification treatment process.
  • extracts from various parts of ume may have a characteristic odor derived from the raw material, and when a cosmetic composition is constituted, even in a relatively small amount, It may not be negligible to apply to the face. This tendency was particularly remarkable when roots were used.
  • the means for deodorization is not particularly limited as long as the effect of the ume extract is not significantly reduced, and an existing technique used for the same purpose can be applied.
  • One typical method is to use activated carbon.
  • the ume extract is obtained from the ume extract obtained by the method described in Example 1 of the present invention (preferably, an extract of ume root using a ume shoot with a steamed ume branch).
  • an amount corresponding to the above 0.01 to 30 g / 100 g, preferably 0.5 to 20 g / 100 g, more preferably 1 to 10 g / 100 g can be blended, and the ume extract obtained by the method described in Example 1 of the present invention
  • the amount corresponding to the dry powder of the product preferably, the dried powder of the extract of ume root with 95% ethanol
  • each extract may be blended alone in the above amount, or may be blended in combination in the above amount. It is more preferable to combine them.
  • Example 1 Preparation of ume part extract
  • the ume part extract obtained as needed was powdered.
  • the extract with purified water was freeze-dried and powdered. After removing the solvent from the ethanol extract once using an evaporator, an appropriate amount of purified water was added, freeze-dried, and powdered.
  • the steam distilled liquid of a ume fruit or a young branch was prepared as follows.
  • Ume fruit steam distillate Water vapor generated by boiling purified water was applied to 5 to 50% (w / w) of ume fruits, and the water vapor containing aroma components obtained was cooled.
  • Ume Wakae Steam Distillate Water vapor generated by boiling purified water was applied to 0.01 to 10% (w / w) of ume shoots to cool the water vapor containing aroma components obtained.
  • Test method 50 ⁇ L of an evaluation sample prepared using purified water on a 96 well plate, 35 ⁇ L of 0.1 M Tris-HCl buffer, 100 ⁇ L of 1 mM Suc-Ala-Ala-Ala-PNA, 0.25 U / mL (Wako Pure Chemical Industries, Ltd., 15 ⁇ L (derived from porcine pancreas) was added, and after reacting at 37 ° C. for 30 minutes, absorbance at 405 nm was measured with a microplate reader. The inhibition rate was calculated using the following formula with purified water as a control.
  • Test sample 25 (L, 2 mM hypoxanthine 25 (L, 2 mM EDTA 25 (L, 0.5 mM NBT 25 (L, 0.1 M carbonate buffer 100 (L , 30 mU / mL xanthine oxidase (XOD) 50 (L was added, reacted at 37 ° C. for 30 minutes, and the absorbance at 570 nm was measured with a microplate reader. The elimination rate was calculated using the following formula with purified water as a control. .
  • Hydrogen peroxide (H 2 O 2 ) erasing effect test 25 ⁇ L of an evaluation sample prepared with purified water was added to a 96-well plate, and then 10 ⁇ L of 0.15 mM H 2 O 2 and 25 ⁇ l of 0.1 M PIPES buffer (pH 7.0) were added and reacted at 37 ° C. for 20 minutes. . Immediately after the reaction, 172 ⁇ M DA-67 (180 ⁇ L) was added, ethanol (10 ⁇ L) was added, a color reaction was performed at 37 ° C. for 5 minutes, and the absorbance at 630 nm was measured with a microplate reader. The elimination rate was calculated using the following formula with purified water as a control.
  • Hyaluronidase activity inhibitory effect test Evaluation sample prepared using purified water in a 96-well plate 12 ⁇ L, 400U / mL hyaluronidase (SIGMA, cow testis) 12 ⁇ L was mixed and incubated at 40 ° C for 20 minutes, 0.1mg / mL Compound 48/80 12 ⁇ L And react at 40 ° C for 20 minutes, add 12 mg of 1 mg / mL potassium hyaluronate, and react at 40 ° C for 40 minutes.
  • the hyaluronidase activity inhibitory effect is calculated using the following formula.
  • Collagenase activity inhibitory effect test 60 ⁇ L of an evaluation sample prepared using purified water, 480 ⁇ L of 0.5 M pz-peptide adjusted with 0.1 M Tris-HCl buffer (pH 7.1, containing 20 mM CaCl 2 ), and 50 CDU / mL collagenase adjusted with purified water ( 60 ⁇ L (from SIGMA, Clostridium histolyticum ) was added and reacted at 37 ° C. for 30 minutes. Immediately after the reaction, 1.2 mL of 2.5 mM citric acid was added, and then extracted with 5.0 mL of ethyl acetate. After centrifugation, the absorbance at 320 nm of the ethyl acetate layer was measured. Using purified water as a control, the inhibition rate of collagenase activity was calculated using the following formula.
  • Fibroblast activation effect test Normal human dermal fibroblasts (NHDF) were seeded in a 96-well microplate at a density of 7 ⁇ 10 4 cells / cm 2 .
  • NHDF normal human dermal fibroblasts
  • an ⁇ -MEM medium containing 5% fetal bovine serum (FBS) was used and cultured in a CO 2 incubator (5% CO 2 , 37 ° C.) for 24 hours. After 24 hours, each sample was replaced with ⁇ -MEM medium containing 5% FBS, and cultured for 72 hours.
  • FBS fetal bovine serum
  • MTT 3- (4,5-dimethylthiazol-2-yl) -2,5-diphenyltetrazolium bromide
  • DMEM medium supplemented with 1.0 mg / ml and cultured for 4 hours.
  • the produced formazan was extracted with acidic isopropanol, and the absorbance at wavelengths of 570 nm and 630 nm was measured with a plate reader. From the difference between the two measured values (absorbance at 570 nm ⁇ absorbance at 630 nm), the cell activation effect was evaluated using the following formula with the value in the case of addition of purified water as a control as the activation rate of 100%.
  • B16 melanoma cell melanin production inhibitory effect test Prepare B16 melanoma cells in DMEM medium containing 10% fetal bovine serum (FBS) at 12 ⁇ 10 4 cells / mL, seed the cell suspension at 0.5 mL / well in a 24-well plate (2 cm 2 ), 37 ° C, Incubate under 5% CO 2 . After 24 hours, the medium is replaced with 0.1 mg / mL theophylline and DMEM medium (10% FBS) supplemented with the evaluation sample.
  • FBS fetal bovine serum
  • Gelatinase activity inhibitory effect test A 10% SDS polyacrylamide gel containing 0.2% gelatin is prepared without a comb by adding a pre-heated gelatin solution, and the MMP marker (manufactured by Primary Cell Co., Ltd.) is 1/4 and 1.5M Tris-HCl buffer (pH 8.8). Apply the sample diluted in step) and perform electrophoresis. After electrophoresis, wash repeatedly with 2.5% TritonX-100. Cut into strips with a length of 2 cm and a width of 0.4 cm from a position 5 mm below the boundary between the separation gel and the concentrated gel.
  • Hyaluronidase activity inhibitory effect The lyophilized product obtained by the method of Example 1 was redissolved in each solvent and used for the test. A similar test was conducted for sodium cromoglycate. The test results are shown in the table below.
  • Example 3 activated carbon treatment
  • Example 2 the elastase activity inhibitory effect test was carried out by the method described in Example 2 for the product after the activated carbon treatment, and compared with the result for the product before the treatment.
  • EtOH extraction refers to extraction with 95% ethanol (the same applies to the following examples unless otherwise noted).
  • the odor derived from the material was reduced, and the activity was not significantly reduced, making it more suitable as a raw material to be added to cosmetics.
  • the aqueous phase A having the composition shown in the following table was heated and dissolved at 85 ° C., B was added, and the mixture was stirred.
  • the oil phase C was heated and dissolved at 100 ° C.
  • the oil phase C was added to the aqueous phase A and B mixture, heated to 85 ° C., and emulsified with an emulsifier. Thereafter, it was cooled to 35 ° C. and subjected to high-pressure treatment (220 MPa ⁇ 5 pass) to obtain a pre-treatment liquid for serum.
  • aqueous phase A shown in the table below was heated and dissolved at 85 ° C. and cooled to 37 ° C.
  • Each component of B was added to aqueous phase A, and C (the essence pretreatment product obtained in the above step (a)) was added to the mixture of aqueous phases A and B, and dispersed uniformly to obtain a essence. .
  • aqueous phase A having the composition shown in the table below was dissolved by heating to 75 ° C., cooled to 35 ° C., added with aqueous phase B, and stirred. Finally, C was added in small portions and stirred to obtain a comparative cosmetic liquid.
  • the sensory test of the manufactured cosmetics was conducted by 20 panelists (general women in their 20s and 60s).
  • the cosmetic liquids of the examples were superior in all items as compared to the comparative examples.
  • Example 5 Preparation of cosmetics, etc.
  • Manufacture of lotion 1 In the following table, heat to 75 ° C and dissolve with stirring. After cooling to 35 ° C., a lotion was obtained.
  • aqueous phase A having the composition shown in the table below is heated to 85 ° C. and dissolved.
  • Add B the pre-treatment for the lotion / milky emulsion obtained in step (a) of lotion 2 and stir. Heat and dissolve only C. C is added to the mixture of A and B, heated to 85 ° C. and emulsified with an emulsifier. The emulsion was cooled to 35 ° C. to obtain an emulsion.
  • Oil phase A having the composition shown in the following table is heated to 100 ° C. and dissolved.
  • Test on blending amount of emulsifier [Test 1] Test method: Add ume extract (dry powder of 95% ethanol extract of Shirakaga ume root) to purified water at a concentration of 0.1 mg / mL (approximately the same as 0.1 mg / g), and add emulsifier (PEG-60 hydrogenated castor oil). The test samples were mixed at the concentrations shown in the table below. In addition, the sample was heated at 80 ° C. to 95 ° C., then mixed by vortexing for 1 minute or longer, and photographed to confirm the presence or absence of precipitation.
  • ume extract dry powder of 95% ethanol extract of Shirakaga ume root
  • emulsifier PEG-60 hydrogenated castor oil
  • Test method A ume extract (dry powder of Shirakaga ume root 95% ethanol extract) was dissolved in purified water at a concentration of 0.25 wt%, and an emulsifier was mixed at the following concentration to prepare a test sample.
  • an emulsifier four kinds of lysolecithin, PEG-60 hydrogenated castor oil, hydrogenated lecithin, and soybean sterol were blended at the same ratio as in Example [Table 9] of the present specification.
  • the sample was heated at 80 ° C. to 95 ° C., then mixed by vortexing for 1 minute or more and cooled to room temperature. The cooled sample was centrifuged at 500 rpm for 2 minutes and photographed to confirm the presence or absence of precipitation.

Abstract

Disclosed is a composition for external application to the skin, which contains an effective amount of an extract of at least one part selected from a root, a branch and a tree bark of plum (Prunus mume) with an aqueous solvent. The composition is particularly useful for the inhibition of an elastase activity and/or the inhibition of a hyaluronidase activity. The plum extract can be used for anti-aging purposes and/or skin whitening purposes.

Description

ウメ抽出物を含む、化粧用組成物Cosmetic composition containing ume extract
 本発明は、ウメの種々の部位からの抽出物を含む組成物に関する。本発明の組成物は、特に、化粧品又は飲食品として有用である。 The present invention relates to a composition containing extracts from various parts of ume. The composition of the present invention is particularly useful as a cosmetic or a food or drink.
 食用のウメ果実を収穫するために、多くのウメが栽培されている一方で、ウメには、食用に適さない種子、剪定や経済寿命による改植等により生じる枝葉、幹、根等、廃棄される部位もまた多く存在する。 While many umes are cultivated to harvest edible ume fruits, umes are discarded as edible seeds, branches, leaves, trunks, roots, etc. resulting from pruning or replanting due to economic life. There are also many sites.
 ウメの種子の有効利用に関しては、例えば、特許文献1は、ウメ種子抽出物を配合することを特徴とする化粧料を提供する。ここでは、ウメ(品種不明)の種子粉砕物から、水、エタノール、1,3-ブチレングリコール、又はメタノールを溶媒として得た抽出物について、ラジカル消去作用、コラゲナーゼ活性阻害作用(コラゲノキットCLN-100を使用。蛍光標識されたI型コラーゲンを使用しているものと思われる。)、ヒアルロニダーゼ活性阻害作用(測定に用いたヒアルロニダーゼの由来等、詳細不明。)、B16細胞における細胞の色相の変化が確認されている。またウメ種子抽出物を含む、化粧水、シャンプー、クリーム、ボディジェル、ヘアパック、顆粒状浴用剤を調製し、官能試験により、使用感等が確認されている。 Regarding effective use of ume seeds, for example, Patent Document 1 provides a cosmetic characterized by blending a ume seed extract. Here, radical scavenging action, collagenase activity inhibitory action (collageno kit CLN-100) was obtained from an extract obtained from ground pulverized seeds of ume (variety unknown) using water, ethanol, 1,3-butylene glycol, or methanol as a solvent. Use: It seems to be using fluorescently labeled type I collagen.), Hyaluronidase activity inhibitory action (details are unknown, such as origin of hyaluronidase used in the measurement), changes in cell hue in B16 cells confirmed Has been. In addition, lotions, shampoos, creams, body gels, hair packs, and granular bath preparations containing ume seed extract have been prepared, and sensory tests have confirmed the feeling of use.
 また、特許文献2~4には、梅木の幹、梅木の枝、梅木の葉、梅木の茎、梅木の根、梅肉、ウメの種殻およびウメの仁からなる群から選択された少なくとも一つから抽出された薬効を有するウメ抽出物を含む、抗酸化剤、胃粘膜損傷抑制剤、糖尿病性神経疾患予防剤、血糖値上昇抑制剤、アルコール吸収抑制剤、血小板凝集促進剤、肝臓炎症抑制剤、抗炎症剤、メラニン色素生成抑制剤を、化粧品が記載されている。これらでは、南高梅の仁及び/又は葉茎部のメタノール抽出物について、ラットにおけるメタノールによる胃粘膜損傷に対する作用、ラジカル(DPPH)消失作用、健常ラットにおける糖負荷後の血糖値上昇抑制作用、アルドース還元酵素阻害作用、健常ウサギ洗浄血小板を血小板活性化因子(PAF)で刺激した際の凝集促進作用、健常マウスにおけるD-ガラクトサミン/LPS誘発性肝臓炎症抑制作用、ラット初代培養肝細胞におけるD-ガラクトサミン誘発急性肝炎抑制作用、及びLPS刺激による健常マウス腹腔内マクロファージからのNO酸性抑制作用が確認され、またウメの花メタノール抽出物の、チロシナーゼ阻害作用、ラジカル(DPPH)消失作用、及び健常ウサギ洗浄血小板を血小板活性化因子(PAF)で刺激した際の凝集促進作用が確認されている。そして、このような作用に関与していると推察される化合物として、3β-hydroxy-12-olean-28-oic acid、2'''-O-Acetylrutin、Eugenylglucoside、Benzyl Glucopyranoside、及びBezyl alcohol xylosyl(1→6)glucoside等が挙げられている。 Patent Documents 2 to 4 include at least one selected from the group consisting of plum tree trunks, plum tree branches, plum tree leaves, plum tree stems, plum tree roots, plum meat, ume seed shells and ume seeds. Antioxidant, gastric mucosa damage inhibitor, diabetic neurological disease preventive agent, blood sugar level increase inhibitor, alcohol absorption inhibitor, platelet aggregation promoter, liver inflammation inhibitor, Cosmetics are described as anti-inflammatory agents, melanin pigmentation inhibitors. In these, methanol extract of Minamitakaume Jin and / or leaf stem part has an effect on gastric mucosal damage by methanol in rats, a radical (DPPH) elimination effect, an inhibitory effect on blood sugar level increase after glucose load in healthy rats, Inhibition of aldose reductase, promotion of aggregation when platelets of healthy rabbits were washed with platelet-activating factor (PAF), suppression of D-galactosamine / LPS-induced liver inflammation in healthy mice, D-in rat primary cultured hepatocytes Inhibition of galactosamine-induced acute hepatitis and inhibition of NO acid from macrophages in the abdominal cavity of healthy mice by stimulation with LPS, tyrosinase inhibitory action, radical (DPPH) elimination action, and washing of healthy rabbits of ume flower methanol extract Aggregation-promoting action has been confirmed when platelets are stimulated with platelet-activating factor (PAF)The compounds presumed to be involved in such actions include 3β-hydroxy-12-olean-28-oic acid, 2 '' '-O-Acetylrutin, Eugenylglucoside, Benzyl Glucopyranoside, and Bezyl alcohol xylosyl ( 1 → 6) Glucside etc. are mentioned.
 さらに特許文献5には、ウメの果実部からの抽出物を有効成分として含有することを特徴とするコラーゲン産生促進剤が記載されている。ここでは、ウメ(品種不明)の果実部を洗浄・破砕・脱核した後搾汁して得た果汁の乾燥物から、エタノール及び水の混合溶媒により得た抽出物について、ヒトの線維芽細胞におけるコラーゲン産生促進作用(抗ヒトコラーゲンタイプI  ウサギIgGを使用。)が確認されている。 Further, Patent Document 5 describes a collagen production promoter characterized by containing an extract from the fruit part of ume as an active ingredient. Here, human fibroblasts are extracted from a dried fruit juice obtained by washing, crushing, and enucleating the ume (variety unknown) fruit juice and using a mixed solvent of ethanol and water. Has been confirmed to promote collagen production (using anti-human collagen type I rabbit IgG).
特開2002-284633号公報JP 2002-284633 A 特開2000-239297号公報JP 2000-239297 A 特開2002-370922号公報JP 2002-370922 A 特開2004-115542号公報JP 2004-115542 A 特開2006-176425号公報JP 2006-176425 A
 本発明者らは、薬理効果の高いウメという素材に着目し、ウメ果汁の発酵液からなることを特徴とする化粧料を開発していた(第2526362号)。今回、ウメという素材を広くとらえ、複数のウメの品種由来の、種々の部位からの抽出物の生理活性について鋭意検討した。そして、高いコラゲナーゼ活性阻害作用の他、エラスターゼ活性阻害作用、ゼラチナーゼ活性阻害作用 、メイラード反応抑制作用等、従来知られていなかった作用を見出し、本発明を完成するに至った。 The present inventors have focused on a material called ume having a high pharmacological effect, and have developed a cosmetic characterized by comprising a fermented ume juice (No. 2526362). In this study, we studied the bioactivity of extracts from various parts from a variety of ume varieties. Then, in addition to the high collagenase activity inhibitory action, the present inventors have completed the present invention by discovering previously unknown actions such as elastase activity inhibitory action, gelatinase activity inhibitory action, Maillard reaction inhibitory action and the like.
 本発明は以下を提供する:
[1]  ウメの、根、枝及び樹皮より選択される一種又は二種以上の部位からの、水、水蒸気、精製水、鉱泉水、エタノール、プロピレングリコール、及び1,3-ブチレングリコールからなる群から選択される一種又は二種以上の溶媒による抽出物を、乾燥粉末として、0.05~250mg/100g、及び乳化剤を0.015~5g/100g含む化粧用組成物。

[2]  乳化剤が、リゾレシチン、PEG-60水添ヒマシ油、水添レシチン、ダイズステロール、またはこれらのいずれかの組み合わせである、[1]に記載の組成物。
[3]  ウメの根の、水抽出物及びエタノール抽出物を配合した、[1]に記載の組成物。
[4]  ウメの根の、エタノール抽出物及び/又は水抽出物を、対象の皮膚へ適用し、それにより対象の皮膚における、エラスターゼ活性及び/又はヒアルロニダーゼ活性を阻害する工程を含む、エラスターゼ活性及び/又はヒアルロニダーゼ活性の阻害により改善される皮膚状態の処置方法。
[5]  老化の進行の抑制のための方法である、[4]に記載の方法。
[6]  さらに、対象の皮膚におけるメイラード反応、又はメラニン産生を抑制する工程を含み、皮膚の美白のための方法でもある、[4]又は[5]に記載の方法。
The present invention provides the following:
[1] A group consisting of water, water vapor, purified water, mineral water, ethanol, propylene glycol, and 1,3-butylene glycol from one or more sites selected from roots, branches and bark of ume A cosmetic composition containing, as a dry powder, 0.05 to 250 mg / 100 g of an extract from one or more solvents selected from the group consisting of 0.015 to 5 g / 100 g of an emulsifier.

[2] The composition according to [1], wherein the emulsifier is lysolecithin, PEG-60 hydrogenated castor oil, hydrogenated lecithin, soybean sterol, or any combination thereof.
[3] The composition according to [1], wherein a water extract and an ethanol extract of ume root are blended.
[4] applying an ethanol extract and / or an aqueous extract of ume root to the subject's skin, thereby inhibiting elastase activity and / or hyaluronidase activity in the subject's skin and A method of treating a skin condition that is improved by inhibiting hyaluronidase activity.
[5] The method according to [4], which is a method for suppressing the progress of aging.
[6] The method according to [4] or [5], further comprising a step of suppressing Maillard reaction or melanin production in the subject's skin, which is also a method for whitening the skin.
図1は、ゼラチナーゼ活性阻害効果試験の結果を示した写真である。FIG. 1 is a photograph showing the results of a gelatinase activity inhibitory effect test. 図2は、メイラード反応抑制効果試験の結果を示した写真である。FIG. 2 is a photograph showing the results of the Maillard reaction inhibitory effect test. 図3は、乳化剤の配合量を検討するための試験の結果を示した写真である。FIG. 3 is a photograph showing the results of a test for examining the amount of emulsifier. 図4は、乳化剤の配合量を検討するための試験の結果を示した写真である。FIG. 4 is a photograph showing the results of a test for examining the amount of emulsifier.
 本発明において「ウメ」とは、バラ科サクラ属の落葉高木である、ウメ(梅、学名:Prunus mume)を指す。ウメは大きく分けて花梅・実梅に分けることができる。 In the present invention, “ume” refers to ume (plum, scientific name: Prunus mume), which is a deciduous tree of the genus Rosaceae. Ume can be roughly divided into flower plums and real plums.
 花梅はさらに3系(野梅系・緋梅系・豊後系)に分けられる。野梅系の例は、一重冬至、満月、竜眠、寒衣、二重冬至、花香実、月宮殿、見鷹玉垣、思いのまま、八重海堂、紅筆、八重紅筆、玉拳、白難波、月の桂、月影、緑であり、緋梅系(紅梅系)の例は、紅千鶴、玉光、唐梅、鹿児島、緋の司、黒雲、であり、豊後系の例は、真鶴、揚羽の蝶、海棠梅、藤牡丹、白獅子、八重揚羽、呉服、武蔵野、一の谷、江南無所、三国一である。花梅-豊後系は、さらに豊後性と杏性に分けることができる。 Hanaume is further divided into 3 types (Noume, Ume and Bungo). Examples of Noume series are single winter solstice, full moon, long sleep, cold clothes, double winter solstice, Hanakami, moon palace, Mitaka Tamagaki, as you wish, Yae Kaido, red brush, Yae red brush, Jade fist, white Namba , Tsuki no Katsura, Tsukikage, green, examples of Ume series (Red plum series) are Red Chizuru, Tamamitsu, Karaume, Kagoshima, Tsuji no Tsuji, Kuroun, and examples of Bungo series are Manazuru, Yoneha They are butterflies, sea cucumber plums, wisteria peony, white lions, Yae fried feathers, kimonos, Musashino, Ichinotani, Gangnam Mujo, and Mikuni. The Haname-Bungo system can be further divided into Bungo and Apricot.
 実梅の例は、豊後、白加賀、鶯宿、月世界、甲州最小、玉梅、古城、南高である。 Examples of real plums are Bungo, Shirakaga, Bakujuku, Moon World, Koshu Minato, Tammei, Kojo, and Minami High School.
 本発明でウメの品種に関し「豊後」というときは、特に記載した場合を除き、実梅に分類される豊後を指す。 In the present invention, the term “Bungo” for ume varieties refers to Bungo classified as real plum, unless otherwise specified.
 本発明で「ウメ」というときは、特に記載した場合を除き、ウメ植物の植物体又はその一部をいう。「その一部」には、実、種子、器官又はその部分(葉、根、茎、花、雄蕊、雌蘂、それらの片を含む)、植物培養細胞、カルス、プロトプラスト、形質転換植物細胞、形質転換植物体が含まれる。 In the present invention, “ume” refers to a plant body of a ume plant or a part thereof unless otherwise specified. “Parts” include fruits, seeds, organs or parts thereof (including leaves, roots, stems, flowers, stamens, pistils, fragments thereof), plant culture cells, callus, protoplasts, transformed plant cells, traits Converted plants are included.
 本発明でウメに関し、「若枝」というときは、特に記載した場合を除き、春先に伸びる新梢が伸び始めて5~30cm位成長し、枝皮が柔らかい状態の枝をいう。本発明でウメに関し、「根」というときは、細根、中根及び太根を含み、並びに老根及びそれ以外のものを含む。細根とは、直径3mm未満のものをいう。中根とは、直径3mm以上~10mm未満のものをいう。太根とは、直径10mm以上のものをいう。老根とは、樹齢30年以上のウメ植物体より得られる根の総称である。 Referring to ume in the present invention, “Wakae” refers to a branch in which a new tree that grows in early spring begins to grow and grows about 5 to 30 cm, and the skin is soft, unless otherwise specified. With respect to plums in the present invention, the term “root” includes fine roots, medium roots and thick roots, as well as old roots and others. Fine roots are those with a diameter of less than 3 mm. The middle root means one having a diameter of 3 mm or more and less than 10 mm. A radish is one having a diameter of 10 mm or more. Old root is a general term for roots obtained from ume plants over 30 years old.
 本発明においては、ウメのいずれの部位も有効に用いることができるが、種々の効果が期待できるとの観点からは、根及び枝(特に若枝)が好ましく、根がより好ましい。 In the present invention, any part of ume can be used effectively, but from the viewpoint that various effects can be expected, roots and branches (especially young branches) are preferable, and roots are more preferable.
 本発明で「エラスターゼ」というときは、特に記載した場合を除き、エラスチンを典型的な基質とするプロテアーゼをいう。エラスチンは、高等動物の結合組織、腱、大動脈外皮、頚索などを構成する、弾力に富む硬蛋白質の一種である。この蛋白質を構成しているペプチド鎖間には架橋が多く、これが弾性をもたらす。 In the present invention, “elastase” refers to a protease having elastin as a typical substrate, unless otherwise specified. Elastin is a kind of a hard protein that is rich in elasticity and constitutes connective tissues, tendons, aortic skin, cervical cord and the like of higher animals. There are many crosslinks between peptide chains constituting this protein, which brings about elasticity.
 対象のエラスターゼ活性を阻害する能力の有無及び/又はその程度は、当業者であれば適宜、公知の手段を用いて確認・測定することができる。詳細な条件は、本明細書の実施例の項を参照することができる。本発明でエラスターゼ活性の阻害の有無及び/又は程度をいうときは、特に記載した場合を除き、本明細書の実施例に記載した方法に拠る。 The presence or absence of the ability to inhibit the target elastase activity and / or the degree thereof can be appropriately confirmed and measured by those skilled in the art using known means. For detailed conditions, reference can be made to the Examples section of this specification. In the present invention, the presence and / or degree of inhibition of elastase activity is based on the method described in the examples of the present specification, unless otherwise specified.
 本発明で「ゼラチナーゼ」というときは、特に記載した場合を除き、基底膜成分であるIV型コラーゲンを典型的な基質とするプロテアーゼで、マトリックスメタロプロテアーゼ(MMP)群のMMP-2及びMMP-9が含まれる。 In the present invention, the term “gelatinase” is a protease using a type IV collagen that is a basement membrane component as a typical substrate, unless otherwise specified, and is a matrix metalloproteinase (MMP) group of MMP-2 and MMP-9. Is included.
 対象のゼラチナーゼ活性を阻害する能力の有無及び/又は程度は、当業者であれば適宜、公知の手段を用いて確認・測定することができる。例えば、MMP-2、ProMMP-2、ProMMP-9又はこれらの混合物が含まれている、市販のゼラチンザイモ電気泳動用のMMPマーカーを用いて実施することができる。詳細な条件は、本明細書の実施例の項を参照することができる。本発明でゼラチナーゼ活性の阻害の有無及び/又は程度をいうときは、特に記載した場合を除き、本明細書の実施例に記載した方法に拠る。 The presence or absence and / or degree of the ability to inhibit the target gelatinase activity can be confirmed and measured appropriately by those skilled in the art using known means. For example, it can be carried out using a commercially available MMP marker for gelatin zymography, which contains MMP-2, ProMMP-2, ProMMP-9 or a mixture thereof. For detailed conditions, reference can be made to the Examples section of this specification. In the present invention, the presence and / or degree of inhibition of gelatinase activity is based on the method described in the examples of the present specification, unless otherwise specified.
 本発明で「コラゲナーゼ」というときは、特に記載した場合を除き、I型コラーゲンを典型的な基質とするプロテアーゼの一種をいう。コラゲナーゼには、マトリックス・メタロプロテアーゼ(MMP)のうちの、皮膚マトリックスの主な構成成分であるタイプI及びタイプIIIコラーゲンを分解するMMP-1が含まれる。コラーゲンとは、動物の細胞外マトリックスの主成分であり、構造維持という物理的機能を有し、また細胞接着活性を示すことが知られている。皮膚にも多量に含まれ、弾力や強度に関わる。コラーゲンには、I~VIIIが存在する。 In the present invention, “collagenase” refers to a type of protease using type I collagen as a typical substrate, unless otherwise specified. Collagenase includes MMP-1, which is a matrix metalloproteinase (MMP) that degrades type I and type III collagen, which are the main components of the skin matrix. Collagen is a main component of the extracellular matrix of animals, and is known to have a physical function of maintaining the structure and exhibit cell adhesion activity. It is also contained in large amounts in the skin and is related to elasticity and strength. There are I to VIII in collagen.
 対象のコラゲナーゼ活性を阻害する能力の有無及び/又は程度は、当業者であれば適宜、公知の手段を用いて確認・測定することができる。詳細な条件は、本明細書の実施例の項を参照することができる。本発明でコラゲナーゼ活性の阻害の有無及び/又は程度をいうときは、特に記載した場合を除き、本明細書の実施例に記載した方法に拠る。 The presence or absence and / or degree of the ability to inhibit the target collagenase activity can be confirmed and measured appropriately by those skilled in the art using known means. For detailed conditions, reference can be made to the Examples section of this specification. In the present invention, the presence or absence and / or degree of inhibition of collagenase activity is based on the method described in the examples of the present specification, unless otherwise specified.
 本発明で「ヒアルロニダーゼ」というときは、特に記載した場合を除き、ヒアルロン酸を低分子化する酵素であって、ヒアルロン酸のN-アセチル-D-ヘキソサミニド結合を加水分解する酵素をいう。ヒアルロニダーゼは、皮膚に存在する。ヒアルロン酸は、O-β-D-グルクロノシル(1→3)-N-アセチル-β-D-グルコサミニル(1→4)単位の二糖だけの繰返し構造を有するグリコサミノグリカンの一種である。動物の関節液や真皮表層などの結合組織に存在する。 In the present invention, the term “hyaluronidase” refers to an enzyme that lowers the molecular weight of hyaluronic acid, unless otherwise specified, and an enzyme that hydrolyzes the N-acetyl-D-hexosaminide bond of hyaluronic acid. Hyaluronidase is present in the skin. Hyaluronic acid is a kind of glycosaminoglycan having a repeating structure of only disaccharides of O-β-D-glucuronosyl (1 → 3) -N-acetyl-β-D-glucosaminyl (1 → 4) units. It is present in connective tissues such as animal joint fluid and dermis.
 対象のヒアルロニダーゼ活性を阻害する能力の有無及び/又は程度は、当業者であれば適宜、公知の手段を用いて確認・測定することができる。詳細な条件は、本明細書の実施例の項を参照することができる。本発明でヒアルロニダーゼ活性の阻害の有無及び/又は程度をいうときは、特に記載した場合を除き、本明細書の実施例に記載した方法に拠る。 The presence or absence and / or degree of the ability to inhibit the target hyaluronidase activity can be appropriately confirmed and measured by those skilled in the art using known means. For detailed conditions, reference can be made to the Examples section of this specification. In the present invention, the presence and / or degree of inhibition of hyaluronidase activity is based on the method described in the examples of the present specification, unless otherwise specified.
 本発明で「線維芽細胞賦活(活性、効果)」というときは、正常ヒト真皮線維芽細胞(NHDF)の増殖能を高めることができることをいう。細胞の増殖の有無・程度は、生細胞数を計数することにより判定することができる。生細胞数の判定のためには、種々の方法が知られている。 In the present invention, “fibroblast activation (activity, effect)” means that the proliferation ability of normal human dermal fibroblasts (NHDF) can be enhanced. The presence / absence / degree of cell proliferation can be determined by counting the number of living cells. Various methods are known for determining the number of viable cells.
 対象の線維芽細胞賦活する能力の有無及び/又は程度は、当業者であれば適宜、公知の手段を用いて確認・測定することができる。詳細な条件は、本明細書の実施例の項を参照することができる。本発明で線維芽細胞賦活活性の有無及び/又は程度をいうときは、特に記載した場合を除き、本明細書の実施例に記載した方法に拠る。 The presence and / or degree of the ability to activate the target fibroblasts can be confirmed and measured appropriately by those skilled in the art using known means. For detailed conditions, reference can be made to the Examples section of this specification. In the present invention, the presence or absence and / or degree of fibroblast activation activity is based on the method described in the examples of the present specification, unless otherwise specified.
 本発明で「メラニン産生抑制」というときは、特に記載した場合を除き、メラノサイト活性化因子合成阻害、メラノサイト活性化因子の阻害、チロシナーゼ合成・成熟阻害、メラニン合成酵素(チロシナーゼ等)活性阻害、メラニン顆粒取り込み阻害、及びメラニン顆粒の分解促進からなる群から選択される一又は複数の作用により、最終的に、メラニン顆粒の形成が抑制されるか又はメラニン顆粒が減少することをいう。メラニンはチロシン由来の酸化重合体である。メラニン形成は、脊椎動物では神経冠由来の黒色素芽細胞(melanoblast)から分化した黒色素胞・メラノサイト等において起きる。細胞内では、芳香族アミノ酸のチロシンは、メラノソーム内で段階的に変化し、最後に非酵素的に重合してメラニンになり、続いてメラニンの顆粒が形成される。 In the present invention, “melanin production inhibition” refers to inhibition of melanocyte activator synthesis, inhibition of melanocyte activator, tyrosinase synthesis / maturation inhibition, melanin synthase (tyrosinase etc.) activity inhibition, melanin, unless otherwise specified By one or a plurality of actions selected from the group consisting of inhibition of granule uptake and promotion of degradation of melanin granules, it means that formation of melanin granules is finally suppressed or melanin granules are reduced. Melanin is an oxidation polymer derived from tyrosine. In vertebrates, melanogenesis occurs in melanophores and melanocytes differentiated from neural crest-derived melanoblasts. Within the cell, the aromatic amino acid tyrosine changes stepwise within the melanosome, and finally polymerizes non-enzymatically into melanin, followed by the formation of melanin granules.
 一方で、メラニン産生細胞に対して障害性である物質は、メラニン産生を抑制することができるかもしれないが、皮膚外用剤としては好ましくない。したがって、本発明の剤の成分としては、高いメラニン産生抑制活性を有するのみならず、細胞障害性でないことが好ましい。このような好ましい効果は、後述する実施例に記載されているように、メラニン産生抑制率と細胞生存率とを乗じた値により表すことができる。 On the other hand, substances that are toxic to melanin-producing cells may be able to suppress melanin production, but are not preferred as an external preparation for skin. Therefore, it is preferable that the component of the agent of the present invention not only has high melanin production inhibitory activity but is not cytotoxic. Such a preferable effect can be represented by a value obtained by multiplying the melanin production inhibition rate and the cell survival rate, as described in Examples described later.
 対象のメラニン産生抑制能力の有無及び/又は程度、並びに細胞障害性の有無及び/又は程度は、当業者であれば適宜、公知の手段を用いて、例えばB16メラノーマ細胞を用いて、確認・測定することができる。詳細な条件は、本明細書の実施例の項を参照することができる。本発明でメラニン産生抑制活性の有無及び/又は程度をいうときは、特に記載した場合を除き、本明細書の実施例に記載した方法に拠る。 A person skilled in the art confirms and measures the presence and / or degree of the ability to suppress melanin production and the presence and / or degree of cytotoxicity using known means as appropriate, for example, using B16 melanoma cells. can do. For detailed conditions, reference can be made to the Examples section of this specification. In the present invention, the presence and / or degree of melanin production inhibitory activity is based on the method described in the examples of the present specification, unless otherwise specified.
 本発明で「メイラード反応」というときは、特に記載した場合を除き、糖とタンパク質とから、アミノカルボニル反応により、褐色物質(メラノイジン)が生じる反応をいう。メイラード反応は、通常、還元糖とタンパク質のアミノ基とが反応してシッフ塩基を形成した後、アマドリ転位産物(アマドリ化合物)が生成する非酵素的反応である。そして、酸化、脱水、縮合、分子内及び分子間における架橋等の複雑な反応を経て、次第に黄褐色化すると共に、メイラード反応後期段階生成物であるAGEs(advanced glycation endproducts)が産生される。 In the present invention, “Maillard reaction” refers to a reaction in which a brown substance (melanoidin) is generated from a sugar and a protein by an aminocarbonyl reaction, unless otherwise specified. The Maillard reaction is usually a non-enzymatic reaction in which an Amadori rearrangement product (Amadori compound) is generated after a reducing sugar reacts with an amino group of a protein to form a Schiff base. Then, through complex reactions such as oxidation, dehydration, condensation, intramolecular and intermolecular cross-linking, the mixture gradually becomes yellowish brown and AGEs (advanced glycation end products) which are late stage products of the Maillard reaction are produced.
 生体内で起きるメイラード反応は、糖尿病患者等に見られる皮膚の褐色斑の形成に関与すると考えられる。褐色斑の原因となる色素にはAGEが含まれている。生体内のメイラード反応はまた、生活習慣病、老化で促進される疾患(例えば、糖尿病合併症、アルツハイマー病、動脈硬化症)にも関連していることが明らかにされつつある。AGEは、アマドリ転位産物から酸化、脱水、縮合などの複雑な反応を経て生成した種々の構造体の総称であり、これには、カルボキシメチルリジン、ピラリン、ペントシジン、クロスリン、イミダゾロン等が含まれ、また、タンパク質の二量体以上の重合体も、AGEとして知られている。 The Maillard reaction that occurs in vivo is considered to be involved in the formation of brown spots on the skin seen in diabetic patients. AGE is included in the pigment that causes brown spots. In vivo Maillard reaction has also been shown to be associated with lifestyle-related diseases, diseases accelerated by aging (eg, diabetic complications, Alzheimer's disease, arteriosclerosis). AGE is a generic name for various structures produced from the Amadori rearrangement product through complex reactions such as oxidation, dehydration, and condensation, including carboxymethyllysine, pyralin, pentosidine, croslin, imidazolone, etc. A polymer of protein dimer or higher is also known as AGE.
 対象のメイラード反応抑制能力の有無及び/又は程度は、当業者であれば適宜、公知の手段を用いて、例えばアマドリ転位産物の生成の阻害、又はAGE生成の阻害を指標として、確認・測定することができる。詳細な条件は、本明細書の実施例の項を参照することができる。本発明でメイラード反応抑制能力の有無及び/又は程度をいうときは、特に記載した場合を除き、本明細書の実施例に記載した方法に拠る。 The presence and / or extent of the subject's ability to suppress the Maillard reaction is confirmed and measured by a person skilled in the art as appropriate using known means, for example, inhibition of Amadori rearrangement product production or inhibition of AGE production as an indicator. be able to. For detailed conditions, reference can be made to the Examples section of this specification. In the present invention, when the presence and / or degree of Maillard reaction suppression ability is mentioned, it is based on the method described in the examples of the present specification, unless otherwise specified.
 本発明で「抗酸化」というときは、特に記載した場合を除き、活性酸素を抑える(発生させない、消去する、働きを抑える)ことをいう。 In the present invention, the term “antioxidation” means that the active oxygen is suppressed (not generated, erased, or suppressed) unless otherwise specified.
 対象の抗酸化能力の有無及び/又は程度は、当業者であれば適宜、公知の手段を用いて確認・測定することができる。例えば、DPPH(1,1-diphenyl-2-picrylhydrazyl)ラジカル消去、スーパーオキシドディスムターゼ(SOD, Superoxide dismutase)様作用、過酸化水素(H2O2)消去、TRAP(Total Radical-trapping Antioxidant Parameter)、FRAP(Ferric Reducing Ability of Plasma)、β-カロテン退色等を指標とすることができる。 A person skilled in the art can appropriately confirm and measure the presence and / or degree of the antioxidant ability of a subject using known means. For example, DPPH (1,1-diphenyl-2-picrylhydrazyl) radical scavenging, superoxide dismutase (SOD) -like action, hydrogen peroxide (H 2 O 2 ) scavenging, TRAP (Total Radical-trapping Antioxidant Parameter), FRAP (Ferric Reducing Ability of Plasma), β-carotene fading, etc. can be used as indicators.
 本発明において「抗酸化」というときは、DPPHラジカル消去、SOD様作用、過酸化水素(H2O2)消去のための詳細な条件は、本明細書の実施例の項を参照することができる。 In the present invention, when referring to “antioxidation”, detailed conditions for scavenging DPPH radicals, SOD-like action and hydrogen peroxide (H 2 O 2 ) can be referred to the Examples section of this specification. it can.
 本発明で抗酸化能の有無及び/又は程度をいうときは、特に記載した場合を除き、本明細書の実施例に記載した方法(DPPHラジカル消去法、SOD法、H2O2消去法)のいずれかに拠る。 In the present invention, the presence or absence and / or degree of antioxidant ability refers to the methods described in the examples of the present specification (DPPH radical elimination method, SOD method, H 2 O 2 elimination method) unless otherwise specified. It depends on either.
 本発明において「老化の進行の抑制」というときは、老化の進行を遅らせることをいう。老化の進行の抑制は、老化防止、抗老化と表現されることもある。 In the present invention, “suppressing the progress of aging” means delaying the progress of aging. Suppression of the progress of aging is sometimes expressed as anti-aging or anti-aging.
 本発明の組成物に用い得るウメの抽出物は、上記のウメの各部位を溶媒(液体及び気体の状態のものも含む。)で抽出処理して得たものをいう。ウメ各部位は、凍結乾燥してから用いてもよい。抽出する溶媒としては、例えば、水(ウメの特定の部位を水蒸気蒸留に供して得られた液を含む。)、水蒸気、精製水、鉱泉水、低級アルコール類(メタノール、エタノール、1-プロパノール、2-プロパノール、1-ブタノール、2-ブタノール等)、多価アルコール類(グリセリン、プロピレングリコール、1,3-ブチレングリコール等)、ケトン類(アセトン、メチルケトン等)、エーテル類(ジエチルエーテル、テトラヒドロフラン等)が挙げられる。好ましくは水蒸気、精製水、水蒸気蒸留液、鉱泉水、低級アルコール類、多価アルコール類等の極性溶媒が良く、特に好ましくは精製水、水蒸気蒸留液、鉱泉水、エタノール、プロピレングリコール、1,3-ブチレングリコールが良い。これらの溶媒は一種のみ用いてもよく、二種以上を混合して用いても良い。本発明の組成物へはまた、複数の抽出溶媒それぞれから得た抽出物を含ませてもよい。 The extract of ume that can be used in the composition of the present invention refers to a product obtained by extracting each part of the ume with a solvent (including liquid and gaseous states). You may use each part of a ume after freeze-drying. Examples of the solvent to be extracted include water (including a liquid obtained by subjecting a specific portion of ume to steam distillation), steam, purified water, mineral water, lower alcohols (methanol, ethanol, 1-propanol, 2-propanol, 1-butanol, 2-butanol, etc.), polyhydric alcohols (glycerin, propylene glycol, 1,3-butylene glycol, etc.), ketones (acetone, methyl ketone, etc.), ethers (diethyl ether, tetrahydrofuran, etc.) ). Preferred are polar solvents such as steam, purified water, steam distilled liquid, mineral spring water, lower alcohols, polyhydric alcohols, particularly preferably purified water, steam distilled liquid, mineral water, ethanol, propylene glycol, 1,3 -Butylene glycol is good. These solvents may be used alone or in combination of two or more. The composition of the present invention may also contain an extract obtained from each of a plurality of extraction solvents.
 本発明の組成物に、エタノール抽出物(90%以上のエタノールを用いた抽出物)を含ませる場合、本発明者らの検討によると、ウメのエタノール抽出物は難水溶性の成分が含まれており、したがって、組成物中で可溶化し、安定性を高めるために、後述するように、さらに乳化剤を含ませることが好ましい。 When the composition of the present invention contains an ethanol extract (an extract using 90% or more of ethanol), according to the study by the present inventors, the ume ethanol extract contains a hardly water-soluble component. Therefore, in order to solubilize in the composition and enhance the stability, it is preferable to further include an emulsifier as described later.
 本発明者らの検討によると、エタノール抽出物(90%以上の純度のエタノールを用いた抽出物)と水(ウメの特定の部位を水蒸気蒸留に供して得られた液を含む。)抽出物とは異なる効果を奏しうるので、本発明の組成物の特に好ましい態様においては、エタノール抽出物と水抽出物との双方を含むことが好ましい。 According to the study by the present inventors, an ethanol extract (an extract using ethanol having a purity of 90% or more) and water (including a liquid obtained by subjecting a specific part of ume to steam distillation) are extracted. In the particularly preferable embodiment of the composition of the present invention, it is preferable to include both an ethanol extract and a water extract.
 本発明において溶媒の純度や混合溶媒の濃度について表すときは(例えば、95%エタノールというときは)、特に記載した場合を除き、容積に基づいている。 In the present invention, when expressing the purity of the solvent and the concentration of the mixed solvent (for example, 95% ethanol), it is based on the volume unless otherwise specified.
 本発明の特に好ましい態様においては、水蒸気蒸留液が、抽出溶媒として用いられ、またそのまま組成物に添加される。水蒸気蒸留液は、加熱水蒸気を連続的に容器内の対象(例えば、ウメ果実、ウメ若枝)に当て、容器から流出する水蒸気を冷却して捕集することにより得られる。得られる液には、対象に由来する種々の成分が含まれうる。 In a particularly preferred embodiment of the present invention, a steam distilled liquid is used as an extraction solvent and is added to the composition as it is. The steam distilled liquid is obtained by continuously applying heated steam to a target (for example, ume fruit or ume shoots) in a container and cooling and collecting the steam flowing out from the container. The obtained liquid may contain various components derived from the subject.
 本発明の組成物は、2以上の成分からなるものであり、好ましくは皮膚外用として又は食品として適した形態であり、より好ましくは化粧品又は健康食品の形態である。本発明の組成物又は剤には、既存の化粧品等は含まれない。なお、本発明に関し、組成物についての説明は、特に記載した場合を除き、剤にも当てはまる。 The composition of the present invention is composed of two or more components, preferably in a form suitable for external use on the skin or as a food, and more preferably in the form of a cosmetic or health food. The composition or agent of the present invention does not include existing cosmetics and the like. Regarding the present invention, the description of the composition also applies to the agent unless otherwise specified.
 本発明の組成物においては、ウメ抽出物の含量は、目的の効果が発揮される範囲であれば特に制限はない。なお、本発明で剤中のウメ抽出物の含量割合又は濃度をいうときは、特に記載した場合を除き、組成物全重量に対するウメ抽出物の重量に基づいて計算した値である。また、このときウメ抽出物の重量は、特に記載した場合を除き、ウメ部位乾燥物を5%W/Wとなるよう溶媒に浸漬し、20~40℃、3~5日 (中2~4日) 間、抽出を行って得られた抽出液の濾過液又はその乾燥物として表した重量である。すなわち、他の条件で得られた抽出液又は乾燥物については、上記の条件での場合の相当量に換算する。 In the composition of the present invention, the content of the ume extract is not particularly limited as long as the intended effect is exhibited. In addition, when mentioning the content ratio or density | concentration of the ume extract in an agent by this invention, it is the value calculated based on the weight of the ume extract with respect to the composition total weight except the case where it describes especially. At this time, unless otherwise specified, the weight of the ume extract was soaked in a solvent so that the dried ume portion was 5% W / W, and was kept at 20 to 40 ° C. for 3 to 5 days (medium 2 to 4). It is the weight expressed as the filtrate or dried product of the extract obtained by extraction between the two days. That is, the extract or dry matter obtained under other conditions is converted into the equivalent amount under the above conditions.
 本発明の組成物には、所望の効果を損なわない範囲で、通常の外用剤に用いられる成分である油脂類、ロウ類、炭化水素類、脂肪酸類、アルコール類、エステル類、アミノ酸類、ビタミン類、界面活性剤、pH調整剤、防腐剤、香料、保湿剤、粉体、紫外線吸収剤、増粘剤、色素、酸化防止剤、美白剤、抗炎症剤、抗しわ剤、肌荒れ改善剤、ニキビ用薬剤、アルカリ類、キレート剤、金属封鎖剤等の成分を配合することもできる。さらに、通常の浴用添加剤に用いられる成分である硫酸ナトリウム、炭酸水素ナトリウム、炭酸カルシウム、塩化カリウム、油性成分、乳化剤、コハク酸、生薬、無機顔料、香料、及び色素等の成分を配合することもできる。 The composition of the present invention includes fats, waxes, hydrocarbons, fatty acids, alcohols, esters, amino acids, vitamins, which are components used in ordinary external preparations, as long as the desired effects are not impaired. , Surfactants, pH adjusters, antiseptics, fragrances, moisturizers, powders, UV absorbers, thickeners, pigments, antioxidants, whitening agents, anti-inflammatory agents, anti-wrinkle agents, rough skin improvers, Components such as acne agents, alkalis, chelating agents, sequestering agents and the like can also be blended. In addition, ingredients such as sodium sulfate, sodium hydrogen carbonate, calcium carbonate, potassium chloride, oily ingredients, emulsifiers, succinic acid, herbal medicines, inorganic pigments, fragrances, and pigments, which are components used in ordinary bath additives, You can also.
 本発明の組成物はまた、その使用目的に応じて、固形剤、半固形剤、液剤等の各種剤形の組成物に調製することが可能である。本発明の組成物はまた、化粧品、医薬部外品、医薬品のいずれの形態にもできる。化粧品である場合、スキンケア化粧品として洗顔石鹸、洗顔クリーム、洗顔フォーム、化粧水(皮膚に水分や保湿成分を補給し、皮膚をみずみずしく保つもので、通常透明か半透明の液状である。使用目的により、保湿・柔軟用、収れん用、ふき取り用に大別できる。)、美容液(エッセンス)(化粧水と同様に液状で、化粧水よりも粘度が高く、保湿機能とエモリエント効果をあわせもったもの。)、パック、マッサージクリーム、乳液、モイスチャークリーム、リップクリーム等、メーキャップ化粧品としてファンデーション、白粉、口紅、ほほ紅、アイシャドウ等、ボディケア化粧品として石鹸、液体洗浄料、日焼け止めクリーム、入浴剤等、ヘアケア化粧品としてシャンプー、リンス、ヘアトリートメント、整髪料、ヘアトニック、育毛剤、スキャルプトリートメント等とすることができる。また、医薬品である場合、硬膏剤、軟膏剤、パップ剤、リニメント剤、ローション剤とすることができる。なお、本明細書で化粧品の形態についていうときは、特に記載した場合を除き、化粧品辞典(日本化粧品技術者会編、2003年)に拠る。 The composition of the present invention can also be prepared into various dosage forms such as a solid agent, a semi-solid agent, and a liquid agent depending on the purpose of use. The composition of the present invention can be in any form of cosmetics, quasi drugs, and pharmaceuticals. In the case of cosmetics, as skin care cosmetics, facial soap, facial cream, facial cleansing foam, lotion (replenishes the skin with moisture and moisturizing ingredients and keeps the skin fresh and is usually a transparent or translucent liquid. Depending on the intended use. , Moisturizing / softening, astringent, wiping, etc.), beauty essence (essence) (Liquid, like liquid lotion, higher in viscosity than lotion, combined with moisturizing function and emollient effect) .), Packs, massage creams, milky lotions, moisturizing creams, lip balms, etc., makeup cosmetics as foundation, white powder, lipstick, cheeks, eye shadows, etc., body care cosmetics such as soap, liquid detergent, sun cream, bathing agent, etc. , Shampoo, rinse, hair treatment, hair conditioner, hair tonic, as hair care cosmetics Hair dye, can be a scalp treatment and the like. Moreover, when it is a pharmaceutical, it can be set as a plaster, an ointment, a poultice, a liniment, and a lotion. In addition, when it mentions about the form of cosmetics in this specification, it is based on a cosmetics dictionary (Japan Cosmetics Engineers Association, 2003) unless otherwise specified.
 本発明の組成物が美容液の形態である場合、ウメ抽出物を、本発明の実施例1に記載した方法で得た水蒸気蒸留液(好ましくは、ウメ若枝の水蒸気蒸留液)に相当する量として、10~50g/100g、好ましくは15~45g/100g、より好ましくは20~40g/100g配合することができ、また本発明の実施例1に記載した方法で得た水蒸気蒸留液(好ましくは、ウメ果実の水蒸気蒸留液)に相当する量として、35~65g/100g、好ましくは40~60g/100g、より好ましくは45~55g/100g配合することができ、また本発明の実施例1に記載した方法で得たウメ抽出物の乾燥粉末(好ましくは、ウメ根の、95%エタノールによる抽出液の乾燥粉末)に相当する量として、0.05~250mg/100g、好ましくは0.1~15mg/100g、より好ましくは1~10mg/100g配合することができ、また本発明の実施例1に記載した方法で得た抽出液(好ましくは、ウメ根の、精製水抽出液)に相当する量として、0.05~15g/100g、好ましくは0.1~10g/100g、より好ましくは0.5~5g/100g配合することができる。この場合においても、それぞれ上記の量で単独で配合していてもよく、また上記の量で組み合わせて配合もよい。組み合わせることがより好ましい。さらにウメ抽出物の乾燥物を組み合わせて配合してもよい。なお、本発明でウメ抽出物の配合量をいうときは、特に記載した場合を除き、本明細書の実施例1に記載した方法で得た抽出物に相当する量をいう。 When the composition of the present invention is in the form of a cosmetic liquid, an amount corresponding to the steam extract obtained by the method described in Example 1 of the present invention (preferably, a steam distilled liquid of ume shoots). 10 to 50 g / 100 g, preferably 15 to 45 g / 100 g, more preferably 20 to 40 g / 100 g, and a steam distilled liquid obtained by the method described in Example 1 of the present invention (preferably , A steam distilled liquid of ume fruit) can be blended in an amount of 35 to 65 g / 100 g, preferably 40 to 60 g / 100 g, more preferably 45 to 55 g / 100 g. As an amount corresponding to the dried powder of ume extract obtained by the method described above (preferably, dried powder of ume root extract with 95% ethanol), 0.05 to 250 mg / 100 g, preferably 0.1 to 15 mg / 100 g, More preferably, 1-10 mg / 100 g can be blended, and the method described in Example 1 of the present invention As an amount corresponding to the extract obtained in (preferably ume root, purified water extract), 0.05 to 15 g / 100 g, preferably 0.1 to 10 g / 100 g, more preferably 0.5 to 5 g / 100 g may be blended. it can. Also in this case, each may be blended alone in the above amounts, or may be blended in combination in the above amounts. It is more preferable to combine them. Furthermore, you may mix | blend combining the dried material of a ume extract. In addition, when referring to the blending amount of the ume extract in the present invention, it means an amount corresponding to the extract obtained by the method described in Example 1 of the present specification, unless otherwise specified.
 本発明の組成物が化粧水の形態である場合、ウメ抽出物を、本発明の実施例1に記載した方法で得たウメ抽出液(好ましくは、ウメ根の、ウメ若枝水蒸気蒸留液による抽出液)に相当する量として、0.1~20g/100g、好ましくは0.5~10g/100g、より好ましくは1~5g/100g配合することができ、また本発明の実施例1に記載した方法で得たウメ抽出物の乾燥粉末(好ましくは,ウメ根の、95%エタノールによる抽出液の乾燥粉末)に相当する量として、0.1~250mg/100g、好ましくは0.3~15mg/100g、より好ましくは0.5~10mg/100g配合することができる。ウメ抽出液や乾燥物は、それぞれ上記の量で単独で配合してもよく、また組み合わせて配合もよい。組み合わせることがより好ましい。 When the composition of the present invention is in the form of a skin lotion, the ume extract is extracted with the ume extract obtained by the method described in Example 1 of the present invention (preferably, extraction of ume root with a ume shoot branch steam distillate). The amount corresponding to 0.1 to 20 g / 100 g, preferably 0.5 to 10 g / 100 g, more preferably 1 to 5 g / 100 g, was obtained by the method described in Example 1 of the present invention. The amount corresponding to dry powder of ume extract (preferably, dry powder of extract of ume root with 95% ethanol) is 0.1 to 250 mg / 100 g, preferably 0.3 to 15 mg / 100 g, more preferably 0.5 to 10 mg. / 100g can be blended. The ume extract and the dried product may be blended alone in the above amounts or in combination. It is more preferable to combine them.
 別の態様の化粧水である場合、ウメ抽出物を、本発明の実施例1に記載した方法で得たウメ抽出液(好ましくは、ウメ根の、ウメ若枝水蒸気蒸留液による抽出液)に相当する量として、0.01~30g/100g、好ましくは0.05~20g/100g、より好ましくは0.1~10g/100g配合することができ、また本発明の実施例1に記載した方法で得たウメ抽出物の乾燥粉末(好ましくは,ウメ根の、95%エタノールによる抽出液の乾燥粉末)に相当する量として、0.10~250mg/100g、好ましくは0.20~70mg/100g、より好ましくは0.35~35mg/100g配合することができ、また本発明の実施例1に記載した方法で得たウメ水蒸気蒸留液(好ましくはウメ果実の水蒸気蒸留液)に相当する量として、5~70g/100g、好ましくは10~60g/100g、より好ましくは20~50g/100g配合することができる。この場合においても、それぞれの抽出物は、上記の量で単独で配合していてもよく、また上記の量で組み合わせて配合もよい。組み合わせることがより好ましい。 In the case of another embodiment of the skin lotion, the ume extract corresponds to the ume extract obtained by the method described in Example 1 of the present invention (preferably, the extract of the ume root by the ume shoot water vapor distillation solution). 0.01 to 30 g / 100 g, preferably 0.05 to 20 g / 100 g, more preferably 0.1 to 10 g / 100 g, and the amount of ume extract obtained by the method described in Example 1 of the present invention. 0.10-250mg / 100g, preferably 0.20-70mg / 100g, more preferably 0.35-35mg / 100g as an amount corresponding to dry powder (preferably, dried powder of ume root extract with 95% ethanol) In addition, the amount corresponding to the ume steam distillate (preferably ume fruit steam distillate) obtained by the method described in Example 1 of the present invention is 5 to 70 g / 100 g, preferably 10 to 60 g / 100 g, more preferably 20 to 50 g / 100 g can be blended. Also in this case, each extract may be blended alone in the above amount, or may be blended in combination in the above amount. It is more preferable to combine them.
 本発明の組成物が乳液の形態である場合、ウメ抽出物を、本発明の実施例1に記載した方法で得たウメ水蒸気蒸留液(好ましくはウメ果実の水蒸気蒸留液)に相当する量として、20~80g/100g、好ましくは30~70g/100g、より好ましくは40~60g/100g配合することができる。 When the composition of the present invention is in the form of an emulsion, the ume extract is used as an amount corresponding to the ume steam distillate (preferably the ume fruit steam distillate) obtained by the method described in Example 1 of the present invention. 20 to 80 g / 100 g, preferably 30 to 70 g / 100 g, more preferably 40 to 60 g / 100 g.
 別の態様の乳液である場合、ウメ抽出物を、本発明の実施例1に記載した方法で得たウメ抽出液(好ましくは、ウメ根の、ウメ若枝水蒸気蒸留液による抽出液)に相当する量として、0.1~20g/100g、好ましくは0.5~10g/100g、より好ましくは1~5g/100g配合することができ、また本発明の実施例1に記載した方法で得たウメ抽出物の乾燥粉末(好ましくは,ウメ根の、95%エタノールによる抽出液の乾燥粉末)に相当する量として、0.01~250mg/100g、好ましくは0.05~10mg/100g、より好ましくは0.2~5mg/100g配合することができる。この場合においても、それぞれの抽出物は、上記の量で単独で配合していてもよく、また上記の量で組み合わせて配合もよい。組み合わせることがより好ましい。 In the case of the emulsion of another aspect, the ume extract corresponds to the ume extract obtained by the method described in Example 1 of the present invention (preferably, the extract of the ume root by the ume shoots steamed distillate). 0.1 to 20 g / 100 g, preferably 0.5 to 10 g / 100 g, more preferably 1 to 5 g / 100 g, and the dried ume extract obtained by the method described in Example 1 of the present invention. As an amount corresponding to powder (preferably dry powder of extract of ume root with 95% ethanol), 0.01 to 250 mg / 100 g, preferably 0.05 to 10 mg / 100 g, more preferably 0.2 to 5 mg / 100 g Can do. Also in this case, each extract may be blended alone in the above amount, or may be blended in combination in the above amount. It is more preferable to combine them.
 本発明の組成物が多層クリームの形態である場合、本発明の実施例1に記載した方法で得たウメ抽出液(好ましくは、ウメ根の、ウメ若枝水蒸気蒸留液による抽出液)に相当する量として、0.05~10g/100g、好ましくは0.1~5g/100g、より好ましくは0.5~2g/100g配合することができ、また本発明の実施例1に記載した方法で得たウメ抽出物の乾燥粉末(好ましくは,ウメ根の、95%エタノールによる抽出液の乾燥粉末)に相当する量として、0.01~250mg/100g、好ましくは0.05~5mg/100g、より好ましくは0.3~1mg/100g配合することができる。この場合においても、それぞれの抽出物は、上記の量で単独で配合していてもよく、また上記の量で組み合わせて配合もよい。組み合わせることがより好ましい。 When the composition of the present invention is in the form of a multilayer cream, it corresponds to a ume extract obtained by the method described in Example 1 of the present invention (preferably, an extract of ume roots using a ume sap branch steam distillation solution). The amount can be 0.05 to 10 g / 100 g, preferably 0.1 to 5 g / 100 g, more preferably 0.5 to 2 g / 100 g, and the dried ume extract obtained by the method described in Example 1 of the present invention. As an amount corresponding to powder (preferably, dried powder of ume root extract with 95% ethanol), 0.01 to 250 mg / 100 g, preferably 0.05 to 5 mg / 100 g, more preferably 0.3 to 1 mg / 100 g Can do. Also in this case, each extract may be blended alone in the above amount, or may be blended in combination in the above amount. It is more preferable to combine them.
 本発明の組成物がリップベースの形態である場合、本発明の実施例1に記載した方法で得たウメ抽出物の乾燥粉末(好ましくは,ウメ根の、95%エタノールによる抽出液の乾燥粉末)に相当する量として、0.05~250mg/100g、好ましくは0.1~10mg/100g、より好ましくは0.5~5mg/100g配合することができ、また本発明の実施例1に記載した方法で得たウメ抽出液(好ましくは、ウメ根の、ウメ若枝水蒸気蒸留液による抽出液、及び/又はウメ根の、精製水抽出液)を配合することができる。この場合においても、それぞれの抽出物は、上記の量で単独で配合していてもよく、また上記の量で組み合わせて配合もよい。組み合わせることがより好ましい。 When the composition of the present invention is in the form of a lip base, dried powder of ume extract obtained by the method described in Example 1 of the present invention (preferably dried powder of ume root extract with 95% ethanol) ) In an amount of 0.05 to 250 mg / 100 g, preferably 0.1 to 10 mg / 100 g, more preferably 0.5 to 5 mg / 100 g, and the ume obtained by the method described in Example 1 of the present invention. An extract (preferably, an extract of ume roots with a ume shoot steamed distillate and / or a purified water extract of ume roots) can be blended. Also in this case, each extract may be blended alone in the above amount, or may be blended in combination in the above amount. It is more preferable to combine them.
 本発明の組成物が石鹸である場合、ウメ抽出物を、本発明の実施例1に記載した方法で得たウメ抽出液(好ましくは、ウメ根の、ウメ若枝水蒸気蒸留液による抽出液)に相当する量として、0.01~30g/100g、好ましくは0.5~20g/100g、より好ましくは1~10g/100g配合することができ、また本発明の実施例1に記載した方法で得たウメ抽出物の乾燥粉末(好ましくは,ウメ根の、95%エタノールによる抽出液の乾燥粉末)に相当する量として、0.01~250mg/100g、好ましくは0.05~10mg/100g、より好ましくは0.1~5mg/100g配合することができる。この場合においても、それぞれの抽出物は、上記の量で単独で配合していてもよく、また上記の量で組み合わせて配合もよい。組み合わせることがより好ましい。 When the composition of the present invention is a soap, the ume extract is converted into a ume extract obtained by the method described in Example 1 of the present invention (preferably, an extract of ume roots using a ume sap branch steam distillation solution). As a corresponding amount, 0.01 to 30 g / 100 g, preferably 0.5 to 20 g / 100 g, more preferably 1 to 10 g / 100 g can be blended, and the ume extract obtained by the method described in Example 1 of the present invention. As an amount corresponding to the dry powder (preferably, dried powder of ume root extract with 95% ethanol) 0.01 to 250 mg / 100 g, preferably 0.05 to 10 mg / 100 g, more preferably 0.1 to 5 mg / 100 g can do. Also in this case, each extract may be blended alone in the above amount, or may be blended in combination in the above amount. It is more preferable to combine them.
 本発明の組成物が化粧品の形態である場合、特に好ましい態様においては、有効成分であるウメ抽出物以外に、ウメ抽出物を可溶化するために有効な量の乳化剤を含む。乳化剤の共存は、ウメ抽出物の種々の効果、すなわちエラスターゼ活性阻害効果、ゼラチナーゼ活性阻害効果、コラゲナーゼ活性阻害効果、ヒアルロニダーゼ活性阻害効果、線維芽細胞賦活(活性、効果)、メラニン産生抑制効果、メイラード反応抑制効果、抗酸化効果を相乗的に高めることができる。 When the composition of the present invention is in the form of a cosmetic, in a particularly preferred embodiment, in addition to the ume extract as an active ingredient, an effective amount of an emulsifier is included to solubilize the ume extract. The coexistence of emulsifiers is various effects of ume extract, namely elastase activity inhibition effect, gelatinase activity inhibition effect, collagenase activity inhibition effect, hyaluronidase activity inhibition effect, fibroblast activation (activity, effect), melanin production inhibition effect, Maillard The reaction suppressing effect and the antioxidant effect can be synergistically enhanced.
 本発明に用いることができる乳化剤の例は、レシチン、レシチン誘導体、リゾリン脂質、高分子乳化剤、プロピレングリコール脂肪酸エステル、グリセリン脂肪酸エステル、ポリグリセリン脂肪酸エステル、ポリオキシエチレングリセリン脂肪酸エステル、ソルビタン脂肪酸エステル、ポリオキシエチレンソルビタン脂肪酸エステル、ポリオキシエチレンソルビット脂肪酸エステル、ポリオキシエチレンラノリン・ラノリンアルコール・ミツロウ誘導体、ポリオキシエチレン硬化ヒマシ油、ポリオキシエチレンステロール・水素添加ステロール、ポリオキシエチレンアルキルエーテル、ポリオキシエチレンポリオキシプロピレンアルキルエーテル、ポリオキシエチレンアルキルエーテルリン酸・リン酸塩、ポリエチレングリコール脂肪酸エステルである。特に好ましい例は、レシチン及びレシチン誘導体である。レシチン誘導体には、分別レシチン、酵素分解レシチン(リゾレシチンを含む。)、水素添加レシチン(「水添レシチン」ということもある。)である。本発明に用いることのできる乳化剤のより具体的な好ましい例は、ダイズ又は卵黄由来の、リゾレシチン、水素添加レシチン、水素添加リゾレシチン(リゾリン脂質、水素添加リン脂質、水素添加リゾリン脂質と表されることもある。)が挙げられる。レシチン、レシチン誘導体は、組み合わせて用いることもできる。 Examples of emulsifiers that can be used in the present invention are lecithin, lecithin derivatives, lysophospholipid, polymer emulsifier, propylene glycol fatty acid ester, glycerin fatty acid ester, polyglycerin fatty acid ester, polyoxyethylene glycerin fatty acid ester, sorbitan fatty acid ester, poly Oxyethylene sorbitan fatty acid ester, polyoxyethylene sorbit fatty acid ester, polyoxyethylene lanolin, lanolin alcohol, beeswax derivative, polyoxyethylene hydrogenated castor oil, polyoxyethylene sterol, hydrogenated sterol, polyoxyethylene alkyl ether, polyoxyethylene poly Oxypropylene alkyl ether, polyoxyethylene alkyl ether phosphate / phosphate, polyethylene glycol fatty acid ester It is an ether. Particularly preferred examples are lecithin and lecithin derivatives. Lecithin derivatives include fractionated lecithin, enzymatically degraded lecithin (including lysolecithin), and hydrogenated lecithin (sometimes referred to as “hydrogenated lecithin”). More specific preferable examples of the emulsifier that can be used in the present invention are expressed as lysolecithin, hydrogenated lecithin, hydrogenated lysolecithin (lysophospholipid, hydrogenated phospholipid, hydrogenated lysophospholipid) derived from soybean or egg yolk. There is also.). Lecithin and lecithin derivatives can also be used in combination.
 乳化剤の特に好ましい例は、リゾレシチン、PEG-60水添ヒマシ油、水添レシチン、ダイズステロール、またはこれらのいずれかの組み合わせ
 本発明の組成物にウメ抽出物を可溶化するために有効な量の乳化剤が含まれる場合、その配合量は、0.015g/100g以上、好ましくは0.025g/100g、より好ましくは0.05g/100gである。いずれの場合も、5g/100g以下であることが好ましく、2.5g/100g以下であることがより好ましい。上限値は、粘性を考慮して決定してもよい。
Particularly preferred examples of emulsifiers include lysolecithin, PEG-60 hydrogenated castor oil, hydrogenated lecithin, soybean sterol, or any combination thereof in an amount effective to solubilize the ume extract in the composition of the present invention. When an emulsifier is included, the blending amount is 0.015 g / 100 g or more, preferably 0.025 g / 100 g, more preferably 0.05 g / 100 g. In any case, it is preferably 5 g / 100 g or less, more preferably 2.5 g / 100 g or less. The upper limit value may be determined in consideration of viscosity.
 乳化剤がレシチン誘導体である場合、本発明の組成物においては、0.001~10g/100g、好ましくは0.002~5g/100g、より好ましくは0.002~3g/100g配合することができる。 When the emulsifier is a lecithin derivative, the composition of the present invention may contain 0.001 to 10 g / 100 g, preferably 0.002 to 5 g / 100 g, more preferably 0.002 to 3 g / 100 g.
 本発明の組成物が化粧品の形態である場合、特に好ましい態様においては、洗顔後、すぐに用いられる。そのような用い方によりウメ抽出物の種々の効果、すなわちエラスターゼ活性阻害効果、ゼラチナーゼ活性阻害効果、コラゲナーゼ活性阻害効果、ヒアルロニダーゼ活性阻害効果、線維芽細胞賦活(活性、効果)、メラニン産生抑制効果、メイラード反応抑制効果、抗酸化効果を相乗的に高めることができる。 When the composition of the present invention is in the form of a cosmetic, in a particularly preferred embodiment, it is used immediately after washing the face. According to such usage, various effects of ume extract, namely elastase activity inhibitory effect, gelatinase activity inhibitory effect, collagenase activity inhibitory effect, hyaluronidase activity inhibitory effect, fibroblast activation (activity, effect), melanin production inhibitory effect, Maillard reaction inhibitory effect and antioxidant effect can be synergistically enhanced.
 本発明の組成物が化粧品の形態である場合、その製造方法は、ウメ抽出物の効果を著しく減じることがない限り、特に制限はなく、当業者であれば適宜製造することができる。 When the composition of the present invention is in the form of a cosmetic, its production method is not particularly limited as long as the effect of the ume extract is not significantly reduced, and can be appropriately produced by those skilled in the art.
 特に好ましい態様においては、製造工程は、高圧乳化処理工程を含む。これにより、乳化粒子を微細化し安定性の高い乳化状態をつくることができる。比較的分散しにくいウメ抽出物を十分に分散・安定化することができ、配合が容易となる。また、乳化状態の粒子が微細となり、肌なじみが良く、浸透性を高め、ウメ抽出物の種々の効果、すなわちエラスターゼ活性阻害効果、ゼラチナーゼ活性阻害効果、コラゲナーゼ活性阻害効果、ヒアルロニダーゼ活性阻害効果、線維芽細胞賦活(活性、効果)、メラニン産生抑制効果、メイラード反応抑制効果、抗酸化効果を相乗的に高めた化粧品を製造することができる。 In a particularly preferred embodiment, the production process includes a high-pressure emulsification treatment process. Thereby, the emulsified particles can be made fine and an emulsified state with high stability can be created. A ume extract that is relatively difficult to disperse can be sufficiently dispersed and stabilized, facilitating blending. In addition, the emulsified particles become finer, have better skin fit, increase permeability, and various effects of ume extract: elastase activity inhibitory effect, gelatinase activity inhibitory effect, collagenase activity inhibitory effect, hyaluronidase activity inhibitory effect, fiber A cosmetic product that synergistically enhances blast cell activation (activity, effect), melanin production inhibitory effect, Maillard reaction inhibitory effect, and antioxidant effect can be produced.
 特に好ましい態様においては、製造工程は、高圧乳化処理工程とは別に、又は組み合わされて、脱臭工程を含む。本発明者らの検討によると、ウメの種々の部位からの抽出物は、素材に由来する特有の臭いを有することがあり、化粧品組成物を構成した場合に、比較的少量であっても、顔に塗布するには無視できない程度である場合がある。特に、根を用いた場合に、その傾向が顕著であった。 In a particularly preferred embodiment, the production process includes a deodorization process separately from or in combination with the high-pressure emulsification treatment process. According to the study by the present inventors, extracts from various parts of ume may have a characteristic odor derived from the raw material, and when a cosmetic composition is constituted, even in a relatively small amount, It may not be negligible to apply to the face. This tendency was particularly remarkable when roots were used.
 脱臭のための手段としては、ウメ抽出物の効果を著しく減じることがない限り、特に制限はなく、同様の目的で用いられる既存の技術を適用することができる。典型的な方法の一つは、活性炭を用いることである。 The means for deodorization is not particularly limited as long as the effect of the ume extract is not significantly reduced, and an existing technique used for the same purpose can be applied. One typical method is to use activated carbon.
 本発明の組成物が健康食品である場合、ウメ抽出物を、本発明の実施例1に記載した方法で得たウメ抽出液(好ましくは、ウメ根の、ウメ若枝水蒸気蒸留液による抽出液)に相当する量として、0.01~30g/100g、好ましくは0.5~20g/100g、より好ましくは1~10g/100g配合することができ、また本発明の実施例1に記載した方法で得たウメ抽出物の乾燥粉末(好ましくは,ウメ根の、95%エタノールによる抽出液の乾燥粉末)に相当する量として、0.1~200mg/100g、好ましくは0.5~100mg/100g、より好ましくは5~50mg/100g配合することができる。この場合においても、それぞれの抽出物は、上記の量で単独で配合していてもよく、また上記の量で組み合わせて配合もよい。組み合わせることがより好ましい。 When the composition of the present invention is a health food, the ume extract is obtained from the ume extract obtained by the method described in Example 1 of the present invention (preferably, an extract of ume root using a ume shoot with a steamed ume branch). As an amount corresponding to the above, 0.01 to 30 g / 100 g, preferably 0.5 to 20 g / 100 g, more preferably 1 to 10 g / 100 g can be blended, and the ume extract obtained by the method described in Example 1 of the present invention The amount corresponding to the dry powder of the product (preferably, the dried powder of the extract of ume root with 95% ethanol) is 0.1 to 200 mg / 100 g, preferably 0.5 to 100 mg / 100 g, more preferably 5 to 50 mg / 100 g. Can be blended. Also in this case, each extract may be blended alone in the above amount, or may be blended in combination in the above amount. It is more preferable to combine them.
 [実施例1:ウメ部位抽出液の調製]
 ウメの各部位を採取し、凍結乾燥処理を行った。
[Example 1: Preparation of ume part extract]
Each part of the ume was collected and lyophilized.
 凍結乾燥処理を行ったウメ(以下で用いたものも含めて、実施例で用いたウメは、すべて本国内で採取された。)の各部位を、精製水、95 %エタノール又は水蒸気蒸留液に、5%W/Wとなるよう浸漬し、30 ℃、4 日 (中3 日) 間抽出を行った。抽出後に濾紙で簡易的に濾過し、最終的には0.45 μm のフィルターで無菌ろ過を行い、ウメ部位抽出液を作製した。 Each part of freeze-dried ume (all umes used in the examples, including those used below) were collected in this country) into purified water, 95% ethanol or steam distilled liquid. Then, it was soaked to 5% W / W and subjected to extraction at 30 ° C. for 4 days (3 days). After extraction, it was simply filtered with filter paper, and finally filtered aseptically with a 0.45 μm filter to prepare a ume part extract.
 必要に応じて得られたウメ部位抽出液は粉末状にした。精製水による抽出液は凍結乾燥を行い、粉末化した。エタノール抽出液は一度エバポレーターを用いて溶媒を除去した後、適量精製水を加え、凍結乾燥を行い、粉末化した。 The ume part extract obtained as needed was powdered. The extract with purified water was freeze-dried and powdered. After removing the solvent from the ethanol extract once using an evaporator, an appropriate amount of purified water was added, freeze-dried, and powdered.
 なお、ウメ果実又は若枝の、水蒸気蒸留液は、下記のように調製した。 In addition, the steam distilled liquid of a ume fruit or a young branch was prepared as follows.
 ウメ果実水蒸気蒸留液:
 精製水を沸騰させて発生させた水蒸気をウメ果実5~50%(w/w)に当てることにより、得られる芳香成分を含んだ水蒸気を冷却することにより、得た。
Ume fruit steam distillate:
Water vapor generated by boiling purified water was applied to 5 to 50% (w / w) of ume fruits, and the water vapor containing aroma components obtained was cooled.
 ウメ若枝水蒸気蒸留液:
 精製水を沸騰させて発生させた水蒸気をウメ若枝0.01~10%(w/w)に水蒸気を当てることにより、得られる芳香成分を含んだ水蒸気を冷却することにより、得た。
Ume Wakae Steam Distillate:
Water vapor generated by boiling purified water was applied to 0.01 to 10% (w / w) of ume shoots to cool the water vapor containing aroma components obtained.
 [実施例2:抽出液の評価]
 試験方法:
 (1)  エラスターゼ活性阻害効果試験:
 96 well plateに精製水を用いて濃度を調製した評価試料 50μL、 0.1M Tris-HCl緩衝液 35μL、1mM Suc-Ala-Ala-Ala-PNA 100μL、0.25U/mL(和光純薬株式会社製、ブタ膵臓由来)15μLを加え、37℃、30分間反応後、マイクロプレートリーダーにて405nmの吸光度を測定した。精製水を対照とし次式を用いて阻害率を算出した。
[Example 2: Evaluation of extract]
Test method:
(1) Elastase activity inhibitory effect test:
50 μL of an evaluation sample prepared using purified water on a 96 well plate, 35 μL of 0.1 M Tris-HCl buffer, 100 μL of 1 mM Suc-Ala-Ala-Ala-PNA, 0.25 U / mL (Wako Pure Chemical Industries, Ltd., 15 μL (derived from porcine pancreas) was added, and after reacting at 37 ° C. for 30 minutes, absorbance at 405 nm was measured with a microplate reader. The inhibition rate was calculated using the following formula with purified water as a control.
Figure JPOXMLDOC01-appb-M000001
 (2)  DPPHラジカル消去効果試験:
 96 well plateに精製水を用いて濃度を調製した評価試料 15μL、0.2M MES緩衝液 60μL、95% エタノール 50μLを添加し、0.6mM DPPHラジカル 25μLを加え、30℃で30分間反応させマイクロプレートリーダーにて540nmの吸光度を測定した。精製水を対照とし次式を用いて消去率を算出した。
Figure JPOXMLDOC01-appb-M000001
(2) DPPH radical scavenging effect test:
Microplate reader: 15 μL of evaluation sample prepared with purified water in 96 well plate, 15 μL of 0.2 M MES buffer 60 μL, 50 μL of 95% ethanol, 25 μL of 0.6 mM DPPH radical, reacted at 30 ° C. for 30 minutes The absorbance at 540 nm was measured. The elimination rate was calculated using the following formula with purified water as a control.
Figure JPOXMLDOC01-appb-M000002
 (3)  SOD様作用効果試験:
 96 well plateに精製水を用いて濃度を調製した評価試料 25(L、2mM ヒポキサンチン 25(L、2mM EDTA 25(L、0.5mM NBT 25(L、0.1M 炭酸緩衝液 100(Lを添加し、30mU/mLキサンチンオキシダーゼ(XOD) 50(Lを添加し、37℃で30分間反応させマイクロプレートリーダーにて570nmの吸光度を測定した。精製水を対照とし次式を用いて消去率を算出した。
Figure JPOXMLDOC01-appb-M000002
(3) SOD-like effect test:
Test sample 25 (L, 2 mM hypoxanthine 25 (L, 2 mM EDTA 25 (L, 0.5 mM NBT 25 (L, 0.1 M carbonate buffer 100 (L , 30 mU / mL xanthine oxidase (XOD) 50 (L was added, reacted at 37 ° C. for 30 minutes, and the absorbance at 570 nm was measured with a microplate reader. The elimination rate was calculated using the following formula with purified water as a control. .
Figure JPOXMLDOC01-appb-M000003
 (4)  過酸化水素(H 2 O 2 )消去効果試験:
 96 well plateに精製水を用いて濃度を調製した評価試料25μL添加し、さらに0.15mM H2O2 10μL、0.1M PIPES緩衝液(pH 7.0) 25μlを添加し、37℃で20分間反応させた。反応後、速やかに172μM DA-67 180μLを添加した後、エタノール 10μLを加え、37℃で5分間発色反応を行い、マイクロプレートリーダーにて630nmの吸光度を測定した。精製水を対照とし次式を用いて消去率を算出した。
Figure JPOXMLDOC01-appb-M000003
(4) Hydrogen peroxide (H 2 O 2 ) erasing effect test:
25 μL of an evaluation sample prepared with purified water was added to a 96-well plate, and then 10 μL of 0.15 mM H 2 O 2 and 25 μl of 0.1 M PIPES buffer (pH 7.0) were added and reacted at 37 ° C. for 20 minutes. . Immediately after the reaction, 172 μM DA-67 (180 μL) was added, ethanol (10 μL) was added, a color reaction was performed at 37 ° C. for 5 minutes, and the absorbance at 630 nm was measured with a microplate reader. The elimination rate was calculated using the following formula with purified water as a control.
Figure JPOXMLDOC01-appb-M000004
 (5)  ヒアルロニダーゼ活性阻害効果試験:
 96well plateに精製水を用いて濃度を調製した評価試料 12μL、400U/mL ヒアルロニダーゼ(SIGMA社製、牛精巣由来)12μLを混合し40℃で20分間incubationし、0.1mg/mL Compound 48/80 12μLを加え40℃で20分間反応し、1mg/mL  ヒアルロン酸カリウム 12μLを加え、40℃で40分間反応させる。
Figure JPOXMLDOC01-appb-M000004
(5) Hyaluronidase activity inhibitory effect test:
Evaluation sample prepared using purified water in a 96-well plate 12μL, 400U / mL hyaluronidase (SIGMA, cow testis) 12μL was mixed and incubated at 40 ° C for 20 minutes, 0.1mg / mL Compound 48/80 12μL And react at 40 ° C for 20 minutes, add 12 mg of 1 mg / mL potassium hyaluronate, and react at 40 ° C for 40 minutes.
 その後0.4N NaOH 12μL添加し、氷水で5分間冷却し反応を停止させ、0.8M ホウ酸カリウム溶液 12μLを加え、沸水で3分間加熱後、氷水で10分間冷却する。20mg/mL p-DMAB 180μLを加え、96well plateに180μL分注後、40℃で20分間 反応し、マイクロプレートリーダーにて540nmにおける吸光度を測定した。精製水を対照とし次式を用いて阻害率を算出した。 After that, add 12μL of 0.4N NaOH, cool with ice water for 5 minutes to stop the reaction, add 12μL of 0.8M potassium borate solution, heat for 3 minutes with boiling water, and cool with ice water for 10 minutes. After adding 180 mg of 20 mg / mL p-DMAB and dispensing 180 μL to a 96-well plate, the mixture was reacted at 40 ° C. for 20 minutes, and the absorbance at 540 nm was measured with a microplate reader. The inhibition rate was calculated using the following formula with purified water as a control.
 ヒアルロニダーゼ活性阻害効果の算出:
 以下の式を用いてヒアルロニダーゼ活性阻害効果を算出する。
Calculation of hyaluronidase activity inhibitory effect:
The hyaluronidase activity inhibitory effect is calculated using the following formula.
Figure JPOXMLDOC01-appb-M000005
 (6)コラゲナーゼ活性阻害効果試験:
 精製水を用いて濃度を調製した評価試料60μL、0.1M Tris-HCl緩衝液(pH7.1、20mM CaCl2含有)で調整した0.5M pz-peptide 480μL及び精製水で調整した50CDU/mLコラゲナーゼ(SIGMA社製、Clostridium histolyticum由来)60μLを添加し、37℃で30分間反応させた。反応後、速やかに2.5mM クエン酸 1.2mLを添加し、その後、酢酸エチル 5.0mLで抽出した。遠心分離後、酢酸エチル層の320nmにおける吸光度を測定した。精製水を対照とし次式を用いてコラゲナーゼ活性阻害率を算出した。
Figure JPOXMLDOC01-appb-M000005
(6) Collagenase activity inhibitory effect test:
60 μL of an evaluation sample prepared using purified water, 480 μL of 0.5 M pz-peptide adjusted with 0.1 M Tris-HCl buffer (pH 7.1, containing 20 mM CaCl 2 ), and 50 CDU / mL collagenase adjusted with purified water ( 60 μL (from SIGMA, Clostridium histolyticum ) was added and reacted at 37 ° C. for 30 minutes. Immediately after the reaction, 1.2 mL of 2.5 mM citric acid was added, and then extracted with 5.0 mL of ethyl acetate. After centrifugation, the absorbance at 320 nm of the ethyl acetate layer was measured. Using purified water as a control, the inhibition rate of collagenase activity was calculated using the following formula.
Figure JPOXMLDOC01-appb-M000006
 (7)  線維芽細胞賦活効果試験:
 正常ヒト真皮線維芽細胞(NHDF)を7×104 cell/cm2の密度で96ウェルマイクロプレートに播種した。播種培地は5%ウシ胎児血清(FBS)を含むα-MEM培地を使用して、CO2インキュベーター(5%CO2、37℃)内で24時間培養した。24時間後、各試料を添加した5%FBSを含むα-MEM培地に置換し、72時間培養した。上清を除いた後、MTT(3-(4,5-ジメチルチアゾール-2-イル)-2,5-ジフェニルテトラゾリウムブロミド)を1.0 mg/ml添加したDMEM培地に交換し、4時間培養した。その後、生成したホルマザンを酸性イソプロパノールにより抽出し、波長570 nm、630 nmの吸光度をプレートリーダーで測定した。両測定値の差(570 nmの吸光度-630 nmの吸光度)から、コントロールである精製水添加の場合の値を賦活率100%とする以下の式を用いて細胞賦活効果を評価した。
Figure JPOXMLDOC01-appb-M000006
(7) Fibroblast activation effect test:
Normal human dermal fibroblasts (NHDF) were seeded in a 96-well microplate at a density of 7 × 10 4 cells / cm 2 . As a seeding medium, an α-MEM medium containing 5% fetal bovine serum (FBS) was used and cultured in a CO 2 incubator (5% CO 2 , 37 ° C.) for 24 hours. After 24 hours, each sample was replaced with α-MEM medium containing 5% FBS, and cultured for 72 hours. After removing the supernatant, MTT (3- (4,5-dimethylthiazol-2-yl) -2,5-diphenyltetrazolium bromide) was replaced with DMEM medium supplemented with 1.0 mg / ml and cultured for 4 hours. Thereafter, the produced formazan was extracted with acidic isopropanol, and the absorbance at wavelengths of 570 nm and 630 nm was measured with a plate reader. From the difference between the two measured values (absorbance at 570 nm−absorbance at 630 nm), the cell activation effect was evaluated using the following formula with the value in the case of addition of purified water as a control as the activation rate of 100%.
Figure JPOXMLDOC01-appb-M000007
 (8)  B16メラノーマ細胞メラニン産生抑制効果試験:
 B16メラノーマ細胞を12×104cells/mLに10%ウシ胎児血清(FBS)を含むDMEM培地で調製し24 well plate(2cm2)に0.5mL/wellで細胞懸濁液を播種し37℃、5%CO2下で培養する。24時間後、0.1mg/mLテオフィリン及び評価試料添加DMEM培地(10%FBS)に交換する。培地交換2日後、メラニン量はPBSで2回洗浄後、1%TritonX-100・1N NaOHを300μL/wellで添加し、50℃で1時間放置しメラニンを抽出する。抽出液250μLを96 well plateに分注し、450nmにおける吸光度をプレートリーダーで測定し、式1によりメラニン産生抑制率を算出する。生細胞数はMTT法によって行い、式2により細胞生存率を算出する。メラニン産生抑制率と細胞生存率より式3を用いて算出したデータにより評価する。
Figure JPOXMLDOC01-appb-M000007
(8) B16 melanoma cell melanin production inhibitory effect test:
Prepare B16 melanoma cells in DMEM medium containing 10% fetal bovine serum (FBS) at 12 × 10 4 cells / mL, seed the cell suspension at 0.5 mL / well in a 24-well plate (2 cm 2 ), 37 ° C, Incubate under 5% CO 2 . After 24 hours, the medium is replaced with 0.1 mg / mL theophylline and DMEM medium (10% FBS) supplemented with the evaluation sample. Two days after the medium change, the amount of melanin is washed twice with PBS, 1% TritonX-100 · 1N NaOH is added at 300 μL / well, and left at 50 ° C. for 1 hour to extract melanin. 250 μL of the extract is dispensed into a 96-well plate, the absorbance at 450 nm is measured with a plate reader, and the inhibition rate of melanin production is calculated using Equation 1. The number of viable cells is determined by the MTT method, and the cell viability is calculated by Equation 2. Evaluation is based on the data calculated using Equation 3 from the inhibition rate of melanin production and the cell viability.
Figure JPOXMLDOC01-appb-M000008
 (9)  ゼラチナーゼ活性阻害効果試験:
 予め加熱溶解したゼラチン水溶液を加え0.2%ゼラチン含有10%SDSポリアクリルアミドゲルをコームなしで作成し、MMPマーカー (株式会社プライマリーセル製)を1/4に1.5M Tris-HCl 緩衝液 (pH8.8)で希釈したものをアプライし、電気泳動する。泳動後、2.5% TritonX-100で繰り返し洗浄する。分離ゲルと濃縮ゲルの境目から5mm下の位置から、2cmの長さ・0.4cmの幅で短冊状に切断する。サンプルチューブに0.05M Tris-HCl緩衝液(5mM CsCl2、5μM ZnCl2、pH8.0)を1350μL入れ、評価試料を150μL添加する。短冊状に切ったゲルを1本ずつサンプルチューブに入れ、37℃で振とうしながら48時間反応させる。反応後CBB染色液で染色と脱色を行う。脱色後の様子を評価試料の代わりに精製水を添加したものを比較対照として、MMPのバンドの消え方を目視により判定した。
Figure JPOXMLDOC01-appb-M000008
(9) Gelatinase activity inhibitory effect test:
A 10% SDS polyacrylamide gel containing 0.2% gelatin is prepared without a comb by adding a pre-heated gelatin solution, and the MMP marker (manufactured by Primary Cell Co., Ltd.) is 1/4 and 1.5M Tris-HCl buffer (pH 8.8). Apply the sample diluted in step) and perform electrophoresis. After electrophoresis, wash repeatedly with 2.5% TritonX-100. Cut into strips with a length of 2 cm and a width of 0.4 cm from a position 5 mm below the boundary between the separation gel and the concentrated gel. Add 1350 μL of 0.05 M Tris-HCl buffer (5 mM CsCl 2 , 5 μM ZnCl 2 , pH 8.0) to the sample tube, and add 150 μL of the evaluation sample. Put the gels cut into strips one by one into the sample tube, and react for 48 hours while shaking at 37 ° C. After the reaction, stain and decolorize with CBB staining solution. The appearance after decolorization was determined visually by determining the disappearance of the MMP band, using as a comparative control the addition of purified water instead of the evaluation sample.
 (10) メイラード反応抑制効果試験:
 サンプルチューブに0.1M リン酸緩衝液(pH 7.4)800μL、0.1M リン酸緩衝液(pH 7.4)800μL で調製した0.5M リボース40μL、50mg/mL リゾチーム100μLを加え、精製水を用いて濃度を調製した評価試料 60μLを添加した。クリーンベンチ内で0.45μmのフィルターを用いてろ過滅菌し、40℃のインキュベーターで7日間反応させた。反応後、SDS-PAGEにて電気泳動を行い0.1% Coomassie Brilliant Blue  R-250にて染色し脱色後リゾチームの2量体を目視により判定した。判定は評価試料の代わりに精製水を用いたものをネガティブコントロールし、硫酸アミノグアニジンを加えた時の様子をポジティブコントロールとして判定した。
(10) Maillard reaction inhibitory effect test:
Add 0.5 μl ribose 40 μl, 50 mg / ml lysozyme 100 μl prepared with 800 μl 0.1M phosphate buffer (pH 7.4) and 800 μl 0.1M phosphate buffer (pH 7.4) to the sample tube, and adjust the concentration using purified water. 60 μL of the evaluation sample was added. The solution was sterilized by filtration using a 0.45 μm filter in a clean bench, and reacted for 7 days in a 40 ° C. incubator. After the reaction, electrophoresis was performed on SDS-PAGE, staining was performed with 0.1% Coomassie Brilliant Blue R-250, and after decolorization, the lysozyme dimer was visually determined. The determination was made by negative control using purified water instead of the evaluation sample, and the state when aminoguanidine sulfate was added was determined as a positive control.
 結果:
 (1)  SOD様作用効果、DPPHラジカル消去効果、H 2 O 2 消去効果、エラスターゼ活性阻害効果
 実施例1の方法で得た抽出液(原液)を100%として、精製水で希釈して試験に供した。また、ツバキ科植物の抽出液、アスコルビン酸(精製水)、バイカリン(5%DMSO/精製水)についても、同様の試験を行った。試験結果及び効果の認められたものについてのIC50値を、下表に示した。表中、EtOHはエタノールを指す(以下同じ。)。
result:
(1) SOD-like effect, DPPH radical scavenging effect, H 2 O 2 scavenging effect, elastase activity inhibitory effect The extract (stock solution) obtained by the method of Example 1 is made 100% and diluted with purified water for testing. Provided. In addition, the same test was performed on the extract of camellia plants, ascorbic acid (purified water), baicalin (5% DMSO / purified water). The table below shows the IC50 values for the test results and those for which effects were recognized. In the table, EtOH refers to ethanol (the same applies hereinafter).
Figure JPOXMLDOC01-appb-T000009
 白加賀、豊後ともに、若枝及び根に高い活性が認められた。特に若枝に関しては、SOD様作用効果、DPPH消去効果及びH2O2消去効果が顕著であり、また根に関しては、SOD様作用効果、DPPHラジカル消去効果及びエラスターゼ活性阻害効果が顕著であった。
Figure JPOXMLDOC01-appb-T000009
In both Shirakaga and Bungo, high activity was observed in the shoots and roots. In particular, the SOD-like action effect, the DPPH elimination effect, and the H 2 O 2 elimination effect are remarkable for the young branch, and the SOD-like action effect, the DPPH radical elimination effect, and the elastase activity inhibition effect are remarkable for the root.
 (2)  メラニン産生抑制効果
 実施例1の方法で得た抽出液(原液)を100%として、又は実施例1の方法で得た凍結乾燥品を各溶媒に再溶解したものを試験に供した。また、コウジ酸(精製水)についても、同様の試験を行った。試験結果を下表に示した。
(2) Melanin production inhibitory effect The extract (stock solution) obtained by the method of Example 1 was taken as 100%, or the lyophilized product obtained by the method of Example 1 was redissolved in each solvent and used for the test. . A similar test was conducted for kojic acid (purified water). The test results are shown in the table below.
Figure JPOXMLDOC01-appb-T000010
Figure JPOXMLDOC01-appb-T000010
Figure JPOXMLDOC01-appb-T000011
 抽出液での試験においては、供試した濃度においては、白加賀及び豊後の若葉の95%エタノール抽出物、並びに白加賀の葉の95%エタノール抽出物に、高い抑制効果が認められた。白加賀の若葉の95%エタノール抽出物については、生存率も比較的高く、所望の効果(抑制効果が高く、細胞の生存率を低下させない)が認められた。
Figure JPOXMLDOC01-appb-T000011
In the test with the extract, a high inhibitory effect was observed in the 95% ethanol extract of Shirakaga and Bungo young leaves and the 95% ethanol extract of Shirakaga leaves at the tested concentrations. The Shirakaga young leaf 95% ethanol extract also had a relatively high survival rate, and the desired effect (high inhibitory effect and did not reduce cell survival rate) was observed.
 凍結乾燥物での試験においては、表に示したいずれのサンプルについても、濃度依存的なメラニン産生抑制が認められた。白加賀の根の精製水抽出物が生存率も比較的高く、所望の効果(抑制効果が高く、細胞の生存率を低下させない)が最も高かった。 In the test with freeze-dried products, concentration-dependent suppression of melanin production was observed for any of the samples shown in the table. The purified water extract of Shirakaga root also had a relatively high survival rate, and the desired effect (high inhibitory effect and did not reduce the cell survival rate) was the highest.
 (3)  線維細胞賦活効果 
 実施例1の方法で得た凍結乾燥品を各溶媒に再溶解したものを試験に供した。また、アスコルビルリン酸ナトリウムについても、同様の試験を行った。試験結果を下表に示した。
(3) Fibrocyte activation effect
The lyophilized product obtained by the method of Example 1 was redissolved in each solvent and used for the test. Moreover, the same test was done also about sodium ascorbyl phosphate. The test results are shown in the table below.
Figure JPOXMLDOC01-appb-T000012
 根、樹皮、枝からの抽出物に、0.5mg/mL濃度のアスコルビルリン酸ナトリウムを超える高い効果が認められる傾向にあった。
Figure JPOXMLDOC01-appb-T000012
There was a tendency for extracts from roots, bark, and branches to be highly effective over 0.5 mg / mL sodium ascorbyl phosphate.
 (4)  コラゲナーゼ活性阻害効果
 実施例1の方法で得た凍結乾燥品を各溶媒に再溶解したものを試験に供した。また、同様の方法で得たショウガ科植物による抽出液についても、同様の試験を行った。試験結果を下表に示した。
(4) Collagenase activity inhibitory effect The lyophilized product obtained by the method of Example 1 was redissolved in each solvent and used for the test. Moreover, the same test was done also about the extract by the ginger family plant obtained by the same method. The test results are shown in the table below.
Figure JPOXMLDOC01-appb-T000013
 ショウガ科植物よりも低い濃度で、同等の効果が認められた。
Figure JPOXMLDOC01-appb-T000013
Equivalent effects were observed at lower concentrations than Ginger.
 (5)  ヒアルロニダーゼ活性阻害効果
 実施例1の方法で得た凍結乾燥品を各溶媒に再溶解したものを試験に供した。また、クロモグリク酸ナトリウムについても、同様の試験を行った。試験結果を下表に示した。
(5) Hyaluronidase activity inhibitory effect The lyophilized product obtained by the method of Example 1 was redissolved in each solvent and used for the test. A similar test was conducted for sodium cromoglycate. The test results are shown in the table below.
Figure JPOXMLDOC01-appb-T000014
 (6)  ゼラチナーゼ活性阻害効果
 実施例1の方法で得た凍結乾燥品を各溶媒に再溶解したものを試験に供した。精製水及びEDTA(精製水)を比較対照とした。試験結果を図1に示した。
Figure JPOXMLDOC01-appb-T000014
(6) Gelatinase activity inhibitory effect The lyophilized product obtained by the method of Example 1 was redissolved in each solvent and used for the test. Purified water and EDTA (purified water) were used as comparative controls. The test results are shown in FIG.
 白加賀及び豊後のそれぞれの根のエタノール抽出物に、ゼラチナーゼ活性阻害効果が認められた。 Inhibition of gelatinase activity was observed in the root ethanol extracts of Shirakaga and Bungo.
 (7)  メイラード反応抑制効果
 実施例1の方法で得た凍結乾燥品を各溶媒に再溶解したものを試験に供した。また、アアミノグアニジン硫酸塩についても、同様の試験を行った。試験結果を図2に示した。
(7) Maillard reaction inhibitory effect The lyophilized product obtained by the method of Example 1 was redissolved in each solvent and subjected to the test. A similar test was also conducted on aaminoguanidine sulfate. The test results are shown in FIG.
 白加賀及び豊後のそれぞれの根の、精製水抽出物及びエタノール抽出物に、高い効果が認められた。若枝については、豊後の精製水抽出物及びエタノール抽出物に効果が認められた。 High effect was observed in purified water extract and ethanol extract of each root of Shirakaga and Bungo. About Wakaeda, the effect was recognized in the purified water extract and ethanol extract of Bungo.
 [実施例3:活性炭処理]
 実施例1の方法で得た抽出液に、活性炭である粒状白鷺WH2c8/32-3(日本エンバイロケミカルズ株式会社)を10%(w/w)、より詳細には、活性炭/(活性炭+抽出液)×100=10 (%w/w)となるように浸漬し、よく撹拌した後、常温 (20℃) で2日間静置した。浸漬後、ろ過して抽出液中の活性炭を除去した。0.45 μm のフィルターでろ過滅菌を行い、臭気について官能試験を行った。
[Example 3: activated carbon treatment]
To the extract obtained by the method of Example 1, 10% (w / w) of granular white birch WH2c8 / 32-3 (Nippon EnviroChemicals Co., Ltd.), more specifically, activated carbon / (activated carbon + extracted liquid) ) × 100 = 10 (% w / w) was immersed and stirred well, and then allowed to stand at room temperature (20 ° C.) for 2 days. After immersion, filtration was performed to remove activated carbon in the extract. Filter sterilization was performed with a 0.45 μm filter, and a sensory test was conducted for odor.
 結果を下表に示した。 The results are shown in the table below.
Figure JPOXMLDOC01-appb-T000015
 また、活性炭処理後のものについて、実施例2に記載の方法でエラスターゼ活性阻害効果試験を行い、処理前のものについての結果と比較した。なお表中、「EtOH抽出」とは、95%エタノールによる抽出を指す(以下の実施例でも、特に記載した場合を除き、同じ。)。
Figure JPOXMLDOC01-appb-T000015
In addition, the elastase activity inhibitory effect test was carried out by the method described in Example 2 for the product after the activated carbon treatment, and compared with the result for the product before the treatment. In the table, “EtOH extraction” refers to extraction with 95% ethanol (the same applies to the following examples unless otherwise noted).
Figure JPOXMLDOC01-appb-T000016
 活性炭処理により、素材に由来するにおいが軽減され、また活性が著しく低下することもなく、化粧品に添加する原料としてより適したものとなった。
Figure JPOXMLDOC01-appb-T000016
By the activated carbon treatment, the odor derived from the material was reduced, and the activity was not significantly reduced, making it more suitable as a raw material to be added to cosmetics.
 [実施例4:使用評価]
 ウメ抽出物を含む美容液を製造し、実際に使用して評価した。
[Example 4: Evaluation of use]
A serum containing ume extract was manufactured and used and evaluated.
 (ウメ抽出物を含む美容液の製造)
 下表の配合の水相Aを85℃に加熱、溶解し、Bを加え、攪拌した。油相Cを100℃加熱、溶解した。水相AとB混合物に油相Cを加え、85℃に加熱し、乳化機で乳化した。その後35℃まで冷却し、高圧処理(220MPa×5 pass)にかけ、美容液前処理物を得た。
(Manufacture of serum containing ume extract)
The aqueous phase A having the composition shown in the following table was heated and dissolved at 85 ° C., B was added, and the mixture was stirred. The oil phase C was heated and dissolved at 100 ° C. The oil phase C was added to the aqueous phase A and B mixture, heated to 85 ° C., and emulsified with an emulsifier. Thereafter, it was cooled to 35 ° C. and subjected to high-pressure treatment (220 MPa × 5 pass) to obtain a pre-treatment liquid for serum.
Figure JPOXMLDOC01-appb-T000017
 次いで、下表の水相Aを85℃に加熱、溶解し、37℃まで冷却した。Bの成分それぞれを水相Aに加え、水相AとBとの混合物に、C(上記工程(a) で得た美容液前処理物)を加え、均一に分散させ、美容液を得た。
Figure JPOXMLDOC01-appb-T000017
Next, the aqueous phase A shown in the table below was heated and dissolved at 85 ° C. and cooled to 37 ° C. Each component of B was added to aqueous phase A, and C (the essence pretreatment product obtained in the above step (a)) was added to the mixture of aqueous phases A and B, and dispersed uniformly to obtain a essence. .
Figure JPOXMLDOC01-appb-T000018
 (比較例美容液の製造)
 他方、下表の配合の水相Aを75℃に加熱して溶解したのち、35℃まで冷却し、水相Bを加え攪拌した。最後にCを少量ずつ加えて攪拌し、比較例美容液を得た。
Figure JPOXMLDOC01-appb-T000018
(Manufacture of comparative serum)
On the other hand, aqueous phase A having the composition shown in the table below was dissolved by heating to 75 ° C., cooled to 35 ° C., added with aqueous phase B, and stirred. Finally, C was added in small portions and stirred to obtain a comparative cosmetic liquid.
Figure JPOXMLDOC01-appb-T000019
 製造された化粧品の官能試験をパネラー20名(20代~60代の一般女性)によって実施した。
Figure JPOXMLDOC01-appb-T000019
The sensory test of the manufactured cosmetics was conducted by 20 panelists (general women in their 20s and 60s).
 上述の美容液を適量(0.2~0.5ml)手に取った後、洗顔後の肌に、右と左の顔に半分ずつ塗布してなじませた。約1ヵ月間、ほぼ一日2回、連続使用し、比較例と比べた結果を以下の基準にて7項目を判定した。 】 After taking an appropriate amount (0.2-0.5ml) of the above-mentioned essence, it was applied to the right and left faces in half on the skin after washing. About 1 month, it was continuously used almost twice a day, and the results compared with the comparative example were judged on the following 7 criteria.
Figure JPOXMLDOC01-appb-T000020
Figure JPOXMLDOC01-appb-T000020
Figure JPOXMLDOC01-appb-T000021
 実施例の美容液は、比較例のものに比べ、すべての項目において優れていた。
Figure JPOXMLDOC01-appb-T000021
The cosmetic liquids of the examples were superior in all items as compared to the comparative examples.
 [実施例5:化粧品等の調製]
 (化粧水1の製造)
下表の配合で、75℃に加熱し、攪拌溶解する。
35℃まで冷却し、化粧水を得た。
[Example 5: Preparation of cosmetics, etc.]
(Manufacture of lotion 1)
In the following table, heat to 75 ° C and dissolve with stirring.
After cooling to 35 ° C., a lotion was obtained.
Figure JPOXMLDOC01-appb-T000022
 (化粧水2の製造)
工程(a) 化粧水・乳液共通前処理:
下表の配合の水相Aと油相Bをそれぞれ溶解する。
水相Aに油相Bを加え、乳化機で乳化する。
乳化物を40℃に加熱し、Cを添加攪拌する。
その後35℃まで冷却し、高圧処理(220MPa×5pass)にかけ、化粧水2前処理物を得た。
Figure JPOXMLDOC01-appb-T000022
(Manufacture of lotion 2)
Process (a) Pre-treatment for lotion and emulsion:
Dissolve water phase A and oil phase B in the composition shown in the table below.
Add oil phase B to water phase A and emulsify with an emulsifier.
The emulsion is heated to 40 ° C. and C is added and stirred.
Thereafter, it was cooled to 35 ° C. and subjected to high-pressure treatment (220 MPa × 5 pass) to obtain a pre-treatment product for lotion 2.
Figure JPOXMLDOC01-appb-T000023
工程(b):
下表の配合の水相Aを80℃に加熱し、溶解する。
40℃まで冷却し、B(上記工程(a)で得た化粧水・乳液共通前処理)を加え攪拌する。
35℃まで冷却し、化粧水2を得た。
Figure JPOXMLDOC01-appb-T000023
Step (b):
The aqueous phase A having the composition shown in the table below is heated to 80 ° C. and dissolved.
Cool to 40 ° C., add B (pretreatment for lotion / milky emulsion obtained in the above step (a)) and stir.
After cooling to 35 ° C., lotion 2 was obtained.
Figure JPOXMLDOC01-appb-T000024
 (乳液の製造)
下表の配合の水相Aを85℃に加熱し、溶解する。
B(上記化粧水2の工程(a)で得た化粧水・乳液共通前処理)を加え、攪拌する。
Cのみを加熱し、溶解する。
AとB混合物にCを加え、85℃に加熱し、乳化機で乳化する。35℃まで冷却し、乳液を得た。
Figure JPOXMLDOC01-appb-T000024
(Manufacture of emulsion)
The aqueous phase A having the composition shown in the table below is heated to 85 ° C. and dissolved.
Add B (the pre-treatment for the lotion / milky emulsion obtained in step (a) of lotion 2) and stir.
Heat and dissolve only C.
C is added to the mixture of A and B, heated to 85 ° C. and emulsified with an emulsifier. The emulsion was cooled to 35 ° C. to obtain an emulsion.
Figure JPOXMLDOC01-appb-T000025
 (クリームの製造)
下表の配合の水相Aと油相Bをそれぞれ80℃に加熱し、溶解する。
BをAに加え、乳化機で乳化する。
35℃まで冷却し、クリームを得た。
Figure JPOXMLDOC01-appb-T000025
(Cream production)
The water phase A and the oil phase B having the composition shown in the table below are heated to 80 ° C. and dissolved.
Add B to A and emulsify with an emulsifier.
Cooled to 35 ° C. to obtain a cream.
Figure JPOXMLDOC01-appb-T000026
 (多層クリームの製造)
工程(a):
下表の配合の水相Aと油相Bをそれぞれ80℃に加熱し、溶解する。
BをAに加え、乳化機で乳化する。
乳化物を高圧乳化(25℃、220Mpa、5pass)にかけ、多層クリーム前処理物を得た。
Figure JPOXMLDOC01-appb-T000026
(Manufacture of multilayer cream)
Step (a):
The water phase A and the oil phase B having the composition shown in the table below are heated to 80 ° C. and dissolved.
Add B to A and emulsify with an emulsifier.
The emulsion was subjected to high-pressure emulsification (25 ° C., 220 MPa, 5 pass) to obtain a multilayer cream pretreatment product.
Figure JPOXMLDOC01-appb-T000027
工程(b):
下表の配合の水相Aと油相Bをそれぞれ80℃に加熱し、溶解する。
BをAに加え、乳化機で乳化する。
乳化物にC(上記工程(a) で得た多層クリーム前処理物)を加え、攪拌し、Dを加えさらに攪拌する。35℃まで冷却、多層クリームを得た。
Figure JPOXMLDOC01-appb-T000027
Step (b):
The water phase A and the oil phase B having the composition shown in the table below are heated to 80 ° C. and dissolved.
Add B to A and emulsify with an emulsifier.
C (the multilayer cream pretreatment product obtained in step (a) above) is added to the emulsion and stirred, and D is added and further stirred. Cooled to 35 ° C. to obtain a multilayer cream.
Figure JPOXMLDOC01-appb-T000028
 (健康食品の製造)
下表の配合の全成分をフリーズドライしたものを混合し、食品を得た。
Figure JPOXMLDOC01-appb-T000028
(Health food production)
The ingredients obtained by freeze-drying all the ingredients shown in the table below were mixed to obtain a food.
Figure JPOXMLDOC01-appb-T000029
 (石鹸の製造)
下表の配合の全成分を均一になるまで加熱し、攪拌溶解する。
濾過、冷却固化、切断、乾燥を経て、洗顔用石鹸を得た。
Figure JPOXMLDOC01-appb-T000029
(Manufacture of soap)
Heat all ingredients in the following table until uniform and stir to dissolve.
A face washing soap was obtained after filtration, cooling, solidification, cutting, and drying.
Figure JPOXMLDOC01-appb-T000030
(リップベースの製造)
下表の配合の油相Aを100℃に加熱し、溶解する。
B(上記美容液の工程(a)で得た美容液前処理)を加え、攪拌する。
脱泡し、あらかじめ30℃にしておいた型に80℃で流し込み、冷却する。
型からはずし、リップベースを得た。
Figure JPOXMLDOC01-appb-T000030
(Manufacture of lip base)
Oil phase A having the composition shown in the following table is heated to 100 ° C. and dissolved.
Add B (the essence pretreatment obtained in step (a) of the essence) and stir.
Defoam and pour into a mold that has been set to 30 ° C. at 80 ° C. and cool.
Removed from the mold to get a lip base.
Figure JPOXMLDOC01-appb-T000031
 [実施例6:乳化剤配合量に関する試験]
〔試験1〕
 試験方法:
 ウメ抽出物(白加賀ウメ根95%エタノール抽出液の乾燥粉末)を0.1mg/mL(0.1mg/gとほぼ同じ)の濃度で精製水に加え、乳化剤(PEG-60水添ヒマシ油)を下表の濃度で混合し、試験サンプルとした。また、サンプルを80℃~95℃で加温した後、1分以上ボルテックスにて混合し、写真撮影を行い、沈殿の有無を確認した。
Figure JPOXMLDOC01-appb-T000031
[Example 6: Test on blending amount of emulsifier]
[Test 1]
Test method:
Add ume extract (dry powder of 95% ethanol extract of Shirakaga ume root) to purified water at a concentration of 0.1 mg / mL (approximately the same as 0.1 mg / g), and add emulsifier (PEG-60 hydrogenated castor oil). The test samples were mixed at the concentrations shown in the table below. In addition, the sample was heated at 80 ° C. to 95 ° C., then mixed by vortexing for 1 minute or longer, and photographed to confirm the presence or absence of precipitation.
 試験結果:
 結果を下表に示した。
Test results:
The results are shown in the table below.
Figure JPOXMLDOC01-appb-T000032
 同じサンプルについて、アングルを変えて撮影した写真を図3に示した。乳化剤の添加により、ウメ抽出物が溶解することがわかった。
〔試験2〕
 試験方法:
 ウメ抽出物(白加賀ウメ根95%エタノール抽出液の乾燥粉末)を0.25wt%濃度で精製水に溶解し、試験1で用いたのと同じ乳化剤を以下の濃度で混合し、試験サンプルとした。検体を80℃~95℃で加温した後、1分以上ボルテックスにて混合し、常温まで冷却した。冷却後のサンプルを、12000rpm、2分の条件で遠心処理し、写真撮影を行い、沈殿の有無を確認した。
Figure JPOXMLDOC01-appb-T000032
A photograph of the same sample taken at different angles is shown in FIG. It was found that the ume extract was dissolved by the addition of the emulsifier.
[Test 2]
Test method:
Ume extract (dry powder of Shirakaga ume root 95% ethanol extract) was dissolved in purified water at a concentration of 0.25 wt%, and the same emulsifier used in Test 1 was mixed at the following concentrations to prepare a test sample. . The sample was heated at 80 ° C. to 95 ° C., then mixed by vortexing for 1 minute or more and cooled to room temperature. The cooled sample was centrifuged at 12000 rpm for 2 minutes and photographed to confirm the presence or absence of precipitation.
 結果: result:
Figure JPOXMLDOC01-appb-T000033
 H-5は、溶解はしているが、粘性が高く、化粧品製造には不向きであった(図4)。
〔試験3〕
 試験方法:
 ウメ抽出物(白加賀ウメ根95%エタノール抽出液の乾燥粉末)を0.25wt%濃度で精製水に溶解し、乳化剤を以下の濃度で混合し、試験サンプルとした。乳化剤としては、リゾレシチン、PEG-60水添ヒマシ油、水添レシチン及びダイズステロールの4種を、本願明細書の実施例[表9]と同じ比率で配合したものを用いた。サンプルを80℃~95℃で加温した後、1分以上ボルテックスにて混合し、常温まで冷却した。冷却後のサンプルを、500rpm ,2分の条件で遠心処理し、写真撮影を行い、沈殿の有無を確認した。
Figure JPOXMLDOC01-appb-T000033
Although H-5 was dissolved, it was highly viscous and unsuitable for cosmetic production (Figure 4).
[Test 3]
Test method:
A ume extract (dry powder of Shirakaga ume root 95% ethanol extract) was dissolved in purified water at a concentration of 0.25 wt%, and an emulsifier was mixed at the following concentration to prepare a test sample. As the emulsifier, four kinds of lysolecithin, PEG-60 hydrogenated castor oil, hydrogenated lecithin, and soybean sterol were blended at the same ratio as in Example [Table 9] of the present specification. The sample was heated at 80 ° C. to 95 ° C., then mixed by vortexing for 1 minute or more and cooled to room temperature. The cooled sample was centrifuged at 500 rpm for 2 minutes and photographed to confirm the presence or absence of precipitation.
 試験結果:
 結果を下表に示した。
Test results:
The results are shown in the table below.
Figure JPOXMLDOC01-appb-T000034
 乳化剤が0.01%に満たない場合は、ウメ抽出物を溶解できないことがわかった。
Figure JPOXMLDOC01-appb-T000034
When the emulsifier was less than 0.01%, it was found that the plum extract cannot be dissolved.

Claims (6)

  1. ウメの、根、枝及び樹皮より選択される一種又は二種以上の部位からの、水、水蒸気、精製水、鉱泉水、エタノール、プロピレングリコール、及び1,3-ブチレングリコールからなる群から選択される一種又は二種以上の溶媒による抽出物を、乾燥粉末として、0.05~250mg/100g、及び乳化剤を0.015~5g/100g含む化粧用組成物。 Selected from the group consisting of water, steam, purified water, mineral water, ethanol, propylene glycol, and 1,3-butylene glycol from one or more sites selected from roots, branches and bark of ume A cosmetic composition comprising 0.05 to 250 mg / 100 g of an extract of one or more solvents as a dry powder and 0.015 to 5 g / 100 g of an emulsifier.
  2. 乳化剤が、リゾレシチン、PEG-60水添ヒマシ油、水添レシチン、ダイズステロール、またはこれらのいずれかの組み合わせである、請求項1に記載の組成物。 2. The composition of claim 1, wherein the emulsifier is lysolecithin, PEG-60 hydrogenated castor oil, hydrogenated lecithin, soybean sterol, or any combination thereof.
  3. ウメの根の、水抽出物及びエタノール抽出物を配合した、請求項1に記載の組成物。 2. The composition according to claim 1, comprising a water extract and an ethanol extract of ume root.
  4. ウメの根の、エタノール抽出物及び/又は水抽出物を、対象の皮膚へ適用し、それにより対象の皮膚における、エラスターゼ活性及び/又はヒアルロニダーゼ活性を阻害する工程を含む、エラスターゼ活性及び/又はヒアルロニダーゼ活性の阻害により改善される皮膚状態の処置方法。 Elastase activity and / or hyaluronidase comprising applying an extract of ume root ethanol and / or water to the skin of the subject, thereby inhibiting elastase activity and / or hyaluronidase activity in the skin of the subject A method of treating a skin condition that is improved by inhibition of activity.
  5. 老化の進行の抑制のための方法である、請求項4に記載の方法。 5. The method according to claim 4, which is a method for suppressing the progress of aging.
  6. さらに、対象の皮膚におけるメイラード反応、又はメラニン産生を抑制する工程を含み、皮膚の美白のための方法でもある、請求項4又は5に記載の方法。 6. The method according to claim 4 or 5, which further comprises a step of suppressing Maillard reaction or melanin production in the subject's skin, which is also a method for whitening the skin.
PCT/JP2011/059358 2010-04-15 2011-04-15 Cosmetic composition containing plum extract WO2011129428A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2010-094031 2010-04-15
JP2010094031A JP4795475B1 (en) 2010-04-15 2010-04-15 Agents containing ume extract

Publications (1)

Publication Number Publication Date
WO2011129428A1 true WO2011129428A1 (en) 2011-10-20

Family

ID=44798796

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2011/059358 WO2011129428A1 (en) 2010-04-15 2011-04-15 Cosmetic composition containing plum extract

Country Status (2)

Country Link
JP (1) JP4795475B1 (en)
WO (1) WO2011129428A1 (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2013144654A (en) * 2012-01-13 2013-07-25 Koshiro Co Ltd Composition for suppressing decrease in contraction force of collagen, containing extract of flower part of prunus mume
CN104173220A (en) * 2013-05-23 2014-12-03 伽蓝(集团)股份有限公司 Novel application of prunus mume extract as effective component for resisting carbonylation
CN104173221A (en) * 2013-05-23 2014-12-03 伽蓝(集团)股份有限公司 Novel application of prunus mume extract
CN109303723A (en) * 2017-07-27 2019-02-05 伽蓝(集团)股份有限公司 Plum blossom embryo extract and its preparation method and application
JP2022134637A (en) * 2021-03-03 2022-09-15 みなべ町 collagenase inhibitor

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5981716B2 (en) * 2011-03-25 2016-08-31 株式会社コーセー Plum vinegar-containing cosmetics and medicinal agents containing ume vinegar as active ingredients
EP3334403B1 (en) 2015-08-10 2021-03-31 Mary Kay, Inc. Topical compositions
CN107019207B (en) * 2016-02-02 2022-03-18 林岳辉 Method for extracting nutrient from plant and nutrient
KR102040245B1 (en) * 2017-04-24 2019-11-07 주식회사 코씨드바이오팜 Skin moisture and anti-aging cosmetic composition with the extract of Aloe Vera by Chojeong mineral water
KR102281703B1 (en) 2017-12-08 2021-07-23 워밀레스 코스메틱스 가부시키가이샤 Cationic vesicles and compositions thereof
CN114569512A (en) * 2022-03-22 2022-06-03 厦门碱起来食品有限公司 Green plum extract and preparation method and application thereof

Citations (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH11335235A (en) * 1998-05-22 1999-12-07 Shiseido Co Ltd Antiaging agent
JP2000191513A (en) * 1998-12-25 2000-07-11 Michio Yoshida Skin washing agent containing agaricus mushroom extract solution
JP2001316221A (en) * 2000-05-10 2001-11-13 Naris Cosmetics Co Ltd Antiaging agent and cosmetic
JP2002201121A (en) * 2000-12-28 2002-07-16 Azuma Noen:Kk Plum water for cosmetic use
JP2002241293A (en) * 2001-02-13 2002-08-28 Ichimaru Pharcos Co Ltd Maillard reaction inhibitor
JP2002284633A (en) * 2001-03-28 2002-10-03 Katakura Chikkarin Co Ltd Cosmetics
JP2002284648A (en) * 2001-03-27 2002-10-03 National Institute Of Advanced Industrial & Technology Composition for hair restorer
JP2002370922A (en) * 2001-06-15 2002-12-24 Azuma Noen:Kk Cosmetic containing japanese plum extract
JP2006096716A (en) * 2004-09-30 2006-04-13 Mitsui Chemicals Inc Improving agent for feeling of use
JP2007038115A (en) * 2005-08-02 2007-02-15 Dainippon Kasei Kk Method of extracting biological origin component
JP2009263275A (en) * 2008-04-25 2009-11-12 Kracie Home Products Ltd Antioxidant and cosmetic product, food and drink composition and pharmaceutical composition containing the same

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4205188B2 (en) * 1997-10-01 2009-01-07 一丸ファルコス株式会社 Maillard reaction inhibitor
JP2001139421A (en) * 1999-11-18 2001-05-22 Takashi Miyazaki Powder mixture for percutaneous/oral administration
JP2001302439A (en) * 2000-04-25 2001-10-31 Matsukawa Kagaku:Kk Cosmetic comprising extract extracted from prenus persia batsh
JP2002080338A (en) * 2000-06-20 2002-03-19 Shiseido Co Ltd Antiaging skin care preparation
JP2002020225A (en) * 2000-07-10 2002-01-23 Naris Cosmetics Co Ltd Humectant composition
JP2004182687A (en) * 2002-12-05 2004-07-02 Kao Corp Elastase inhibitor
JP2005126360A (en) * 2003-10-23 2005-05-19 Masao Tanihara Collagenase inhibitor composed of new polypeptide
JP2006008566A (en) * 2004-06-24 2006-01-12 Ichimaru Pharcos Co Ltd Cosmetic agent containing lactic acid bacteria fermentation product of fruit juice as active ingredient and its application
JP4707997B2 (en) * 2004-07-30 2011-06-22 昭和電工株式会社 L-ascorbic acid-2-phosphate magnesium sodium salt, process for producing the same, and cosmetics containing the salt
JP4634769B2 (en) * 2004-10-04 2011-02-16 独立行政法人産業技術総合研究所 Whitening effect improver, method for producing the same, whitening composition using the same, and external preparation for skin containing the same
JP2006176425A (en) * 2004-12-21 2006-07-06 Maruzen Pharmaceut Co Ltd Collagen production promoter and skin care preparation
WO2008093670A1 (en) * 2007-02-01 2008-08-07 Tk Bio-Research Laboratory Co., Ltd. Fermentation product of grape skin/seed by lactic acid bacteria, and pharmaceutical agent and food utilizing the same
JP5057808B2 (en) * 2007-03-14 2012-10-24 ポーラ化成工業株式会社 Skin external preparation with excellent moisture retention
JP2008266147A (en) * 2007-04-16 2008-11-06 Sapporo Breweries Ltd Extracellular matrix degrading enzyme inhibitor
JP5162174B2 (en) * 2007-07-24 2013-03-13 丸善製薬株式会社 Hair restorer and anti-obesity agent
JP2009051803A (en) * 2007-08-28 2009-03-12 Yoshiaki Nagaura Discovery of new method for extraction
JP2009107983A (en) * 2007-10-31 2009-05-21 Maruzen Pharmaceut Co Ltd Maillard reaction inhibitor, anti-aging agent, and skin preparation for external use
JP2009263279A (en) * 2008-04-25 2009-11-12 Oriza Yuka Kk Elastase inhibitor
JP2010047530A (en) * 2008-08-22 2010-03-04 Intoron:Kk Cosmetic containing plant extract

Patent Citations (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH11335235A (en) * 1998-05-22 1999-12-07 Shiseido Co Ltd Antiaging agent
JP2000191513A (en) * 1998-12-25 2000-07-11 Michio Yoshida Skin washing agent containing agaricus mushroom extract solution
JP2001316221A (en) * 2000-05-10 2001-11-13 Naris Cosmetics Co Ltd Antiaging agent and cosmetic
JP2002201121A (en) * 2000-12-28 2002-07-16 Azuma Noen:Kk Plum water for cosmetic use
JP2002241293A (en) * 2001-02-13 2002-08-28 Ichimaru Pharcos Co Ltd Maillard reaction inhibitor
JP2002284648A (en) * 2001-03-27 2002-10-03 National Institute Of Advanced Industrial & Technology Composition for hair restorer
JP2002284633A (en) * 2001-03-28 2002-10-03 Katakura Chikkarin Co Ltd Cosmetics
JP2002370922A (en) * 2001-06-15 2002-12-24 Azuma Noen:Kk Cosmetic containing japanese plum extract
JP2006096716A (en) * 2004-09-30 2006-04-13 Mitsui Chemicals Inc Improving agent for feeling of use
JP2007038115A (en) * 2005-08-02 2007-02-15 Dainippon Kasei Kk Method of extracting biological origin component
JP2009263275A (en) * 2008-04-25 2009-11-12 Kracie Home Products Ltd Antioxidant and cosmetic product, food and drink composition and pharmaceutical composition containing the same

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2013144654A (en) * 2012-01-13 2013-07-25 Koshiro Co Ltd Composition for suppressing decrease in contraction force of collagen, containing extract of flower part of prunus mume
CN104173220A (en) * 2013-05-23 2014-12-03 伽蓝(集团)股份有限公司 Novel application of prunus mume extract as effective component for resisting carbonylation
CN104173221A (en) * 2013-05-23 2014-12-03 伽蓝(集团)股份有限公司 Novel application of prunus mume extract
CN109303723A (en) * 2017-07-27 2019-02-05 伽蓝(集团)股份有限公司 Plum blossom embryo extract and its preparation method and application
JP2022134637A (en) * 2021-03-03 2022-09-15 みなべ町 collagenase inhibitor
JP7235233B2 (en) 2021-03-03 2023-03-08 みなべ町 collagenase inhibitor

Also Published As

Publication number Publication date
JP4795475B1 (en) 2011-10-19
JP2013163643A (en) 2013-08-22

Similar Documents

Publication Publication Date Title
JP4795475B1 (en) Agents containing ume extract
RU2545708C2 (en) Moringa sp. whole seed extract and using it in cosmetic and/or dermatologic compositions
JP7357983B2 (en) Extract of Moringa peregrina seed solids, method for obtaining same and use thereof in cosmetic product compositions or nutricosmetic compositions
KR101744889B1 (en) Composition for Anti-oxidation, Whitening and Wrinkles protection
KR101095609B1 (en) Cosmetic composition containing whitening Composition for whitening Skin
KR101445642B1 (en) Cosmetic composition comprising the extract of Lagerstroemia indica as active ingredient
US10980736B2 (en) Coconut shell extracts, compositions containing same and uses
KR102561149B1 (en) Composition for improving skin condition comprising herb extracts mixture
JP2012162487A (en) Whitening agent, anti-aging agent and skin cosmetic
KR102573375B1 (en) Composition for improving skin condition comprising herb extracts mixture
KR101176526B1 (en) Cosmetic Composition Comprising the extract of Spiraea prunifolia var.simpliciflora as Active Ingredient
KR20170137405A (en) Composition for improving skin condition comprising herb extracts mixture
KR20170137436A (en) Composition for improving skin condition comprising herb extracts mixture
KR20170137559A (en) Composition for improving skin condition comprising herb extracts mixture
KR102503191B1 (en) Composition for improving skin condition comprising herb extracts mixture
KR102573376B1 (en) Composition for improving skin condition comprising herb extracts mixture
KR102561150B1 (en) Composition for improving skin condition comprising herb extracts mixture
KR101479245B1 (en) Cosmetic composition comprising the extract of Lagerstroemia indica as active ingredient
KR101479244B1 (en) Cosmetic composition comprising the extract of Lagerstroemia indica as active ingredient
KR102561151B1 (en) Composition for improving skin condition comprising herb extracts mixture
KR100516447B1 (en) Cosmetic composition containing root extract with excellent astringent effect
KR102561146B1 (en) Composition for improving skin condition comprising herb extracts mixture
KR20170136922A (en) Composition for improving skin condition comprising herb extracts mixture
KR102573377B1 (en) Composition for improving skin condition comprising herb extracts mixture
KR20170137557A (en) Composition for improving skin condition comprising herb extracts mixture

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 11768949

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 11768949

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: JP